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Abstract 
Background: Globally over a million people are infected daily with a sexually transmitted 
infection (STI), giving rise to a major global health threat. Sexually transmitted infections have 
also been on the rise in Saskatoon Health Region (SHR). The region has the largest number of 
people living with HIV (PLWH) in the province of Saskatchewan. Globally, the prevalence of 
STIs have been reported to be high among PLWH.  The diagnosis of other STIs in PLWH 
suggests the possibility that PLWH are putting non-infected individuals at risk of HIV infection. 
Thus, identification of subgroups of PLWH at risk of acquiring other STIs is essential to guide 
intervention programs, such as to prevent further transmission of HIV and other STIs. Studies 
exploring risk factors for STI acquisition amongst PLWH   are not available in SHR, and limited 
in Canada overall.  
Objectives:  
1. To explore whether either gender or IDU are risk factors for STI acquisition in the year before 
and after HIV diagnosis in SHR. 
2. To determine if gender is a risk factor for acquiring STIs among PLWH in developed 
countries.  
3. To determine if IDU is a risk factor for acquiring STIs among PLWH in developed countries.  
Methods: Objective 1: Saskatoon Health Region health service data on PLWH with and without 
STIs during the years 2009 to 2014 were examined. Twenty-two PLWH with an STI diagnosis 
within a year before and after HIV diagnosis were compared to one hundred and thirty-three 
PLWH without an STI diagnosis for variables potentially associated with STI acquisition in HIV. 
Objective 2&3: A systematic review and meta-analysis was conducted according to Meta-
analysis of Observational Studies in Epidemiology (MOOSE) and Effective Public Health 
Practice Project (EPHPP) recommendations. Its reporting was guided by Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Studies from developed 
countries addressing acquisition of other STIs in PLWH were identified. Relevant data were 
abstracted and differences in odds ratios (OR) across the studies and heterogeneity were 
examined using meta-analysis. 
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Results  
Objective 1:  
Multivariable analysis showed an association with marginal statistical significance between 
female gender (OR: 4.99; CI: 0.89-27.3) and the risk for STI acquisition in the year before and 
after HIV diagnosis in SHR. There was also a significant association between sex work (OR: 5.0; 
CI: 1.03 -24.6) and the risk for STI acquisition in PLWH during this period in SHR. No 
association was observed between IDU and the risk for STI acquisition in the year before and 
after HIV diagnosis in SHR (OR: 0.20; CI: 0.03-1.2). No interaction was observed between the 
variables. 
Objectives 2 & 3: Ten articles were reviewed for the gender analysis.The pooled OR for HIV-
infected females acquiring other STIs compared to males was 1.38 (CI: 0.75-2.55), with a high 
heterogeneity of I2 = 96%. For the IDU analysis, six articles were reviewed.  The pooled OR for 
IDUs acquiring other STIs compared to non-IDU was 0.71 (CI: 0.4-1.29), with a high 
heterogeneity of I2 = 85%.  
Conclusion: In the face of scarce resources public health practitioners should prioritize programs 
to address HIV subgroups more at risk for STI acquisition. Special programs may also be 
necessary to reach certain high-risk groups.  
Keyword: HIV, Sexually Transmitted Infections, Injection Drug Use, Gender, Developed 
Countries 
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Chapter 1: Introduction 
This section provides the study rationale, gives background on the association between human 
immunodeficiency virus (HIV) and STIs. It also states the purpose and objectives of the study. 
Lastly, it describes the theoretical perspective and conceptual framework (CF) which was used to 
guide the study. 
      1.1 Study rationale 
The effect of STIs on health morbidity and mortality cannot be overemphasized, with over 340 
million newly diagnosed STIs (other than HIV) in 1999. (1) The presence of other STIs among 
PLWH contributes to further transmission of HIV. (2) More than a million people are infected 
daily with an STI, giving rise to a major global health threat. (3) Despite the availability of 
antiretroviral therapy (ART) for PLWH, coexisting STIs remain a major risk factor to be 
considered for HIV transmission. (2) The incidence of STIs in PLWH was observed to be on the 
rise since early 2000’s. (2, 4) This could be because PLWH are living longer due to the advent of 
ART or even decrease stigma to HIV. 
A synergistic epidemic is said to occur between HIV and other existing STIs partly as a result of 
high-risk health behavior found among people with HIV and other STIs.(4, 5) Some high-risk 
behaviors include sex work, unsafe sex with casual and multiple partners, and sexual practice 
influenced by substance abuse.(4) Studies in the past had reported that STI coexisting with HIV 
can serve as a marker for continued sexual risk behavior.(6-9) Several studies had reported the 
presence of other STIs in PLWH.(6-10) Kalichman et al. (2011) recorded a co-infection 
prevalence of 16.3%, with median prevalence of 9.5%, 9.5%and 5% for syphilis, gonorrhea and 
chlamydia respectively.(10) 
Some studies documented an increased risk of HIV transmission when the infection co-existed 
with other STIs, especially in the presence of inflammation and ulcers. (11-13) This increases the 
probability of transmission of HIV and susceptibility to the virus. Co-infection with STIs is a 
recognised threat to the health of PLWH.(10)  The presence of
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 STIs among this population increases the HIV viral load (VL) in both genital and anal 
secretions. (5, 12, 14) Generally, the concentration of HIV VL is lower in genital secretions 
compared to blood plasma, but with STI and HIV co-infection this is usually reversed.(10) The 
rise in VL in PLWH may be due to a number of factors, of which co-infection with other STIs 
plays a significant role. (2- 5, 12) 
 A study reported that HIV positive men with urethritis had an increased HIV VL in their semen, 
with their VL being eight times more compared to HIV positive men without urethritis.(12) After 
treating urethritis in these men, their semen VL was found to decrease tenfold compare to pre-
treatment levels.(12) The increase HIV transmission is particularly higher in the presence of STI 
with inflammation and ulcer, and this increases infectiousness of the virus and susceptibility to 
HIV infection.(4, 13) The probability of HIV transmission increases with a rise in VL. For 
example, 100,000 viruses per ejaculation has the probability of HIV transmission of 1 in 100 
episodes of intercourse compared to 1,000 viral copies which has a probability of 3 HIV 
transmission per 10,000 intercourse episodes. (5, 14) The presence of STIs not only increases VL 
in affected patients but it also suppresses the CD4 counts (15), which increases susceptibility of 
an HIV-infected person to another STI. The alteration of these two clinical factors increase the 
risk of transmission of HIV especially in PLWH who are not on ART. (15) This evidence has 
been supported by other studies. (16–20) 
Sexually transmitted infection co-existing with HIV has also been reported to hamper the ability 
of antiretroviral therapy (ART) to reduce genital infectiousness in about 15% of PLWH on 
treatment.(11) Sadiq and his colleagues backed up this finding in a research in 2005.(21) From 
the above discussion, we can observe that the overall health of PLWH may be hampered by co-
existence of STIs.(22) This is particularly because it is more challenging to treat PLWH with a 
suppressed immune status.(22) 
A mathematical equation developed by May and Anderson in 1987 can be used to determine the 
transmission of STIs in PLWH. (11, 13) 
R0 = βDC  
β = Probability of transmission,  
D = Duration of infectiousness and  
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C = Measure of number of susceptible individuals in contact with infected person. 
The three determinants of transmission of STIs in PLWH (β, D, C), do vary in distribution from 
one group of people to another (11), thus pointing out the reasons STIs behave differently in 
these groups.(11) The determinants are greatly influenced by multiple factors which includes 
social, economic, demographic, cultural, and behavioral factors at both individual and population 
level.(11) In view of this, we need to decipher which of these factors are drivers for the 
acquisition of STIs amongst PLWH in different contexts and understand how they influence each 
other.(11)Co-infection between HIV and other STIs affect the risk of transmission of both 
diseases.(23) Assessing a temporal relationship between HIV and other STIs is difficult  because 
some STIs only become symptomatic upon diagnosis of HIV infection.(24) This emphasizes the 
need to routinely screen for STIs in PLWH.(24) Despite the fact that research is limited in this 
area, some papers have highlighted factors contributing to the risk of acquiring  STIs in 
PLWH.(10,24-27) These factors include the ability of HIV infection to suppress the immunity of 
PLWH, thus increasing their susceptibility to acquire STIs.(10) Risky sexual behavior such as 
unprotected sex and having multiple sexual partners were also found to contribute to acquiring 
STIs in PLWH.(10, 24-27) Previous STIs also contribute to the acquisition of STIs in PLWH, 
especially when these STIs are undiagnosed and untreated.(10, 24-25) Almost a third of clients 
with HIV and STI co-infection (HIV/STI), in a study conducted in Spain, had a previous STI 
history. (28) The odds of having co-infection with previous STI in the study was four times more 
than individuals without previous STI. (28) 
Risk of STIs transmission in PLWH was also reportedly affected by younger age, CD4 counts, 
VL, use of illicit drugs, alcohol and lack of social support. (25-27) Prevalence varies by study for 
STIs diagnosed among PLWH. Hague et al. (2011) reported STI co-infections in PLWH, among 
these, 58.5% were gonorrhea, 26.4% were syphilis, and 15.1% were chlamydia (6).  While 
Asavapiriyanont et al. (2013) observed 6.6% co-infections with chlamydia, 1.0%, with 
gonorrhea, and 0.7%, with syphilis.(29) A Canadian study by Romanoski et al. (2009) reported 
that 54% of these patients had co-infection with genital herpes.(31) About 50% of new cases of 
syphilis in Canada were found in PLWH.(31) Recent studies have indicated that prevention of 
HIV transmission is better achieved when targeted at PLWH, as they are the main source of 
transmission.(4) This type of prevention is referred to as positive prevention.(4) With the recent 
economic crisis information on factors contributing to the spread of new HIV infection can 
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inform decisions about resource allocation to support priority prevention programs in combating 
spread of infection.(32) The direct cost of HIV to Saskatchewan’s health care system is 
estimated at about forty million dollars while indirect cost is approximately 2.4 times that of 
direct cost.(33) 
HIV prevention programs globally do not include routine screening for STIs in PLWH.  (34) 
Generally, data for STIs are underreported, and this makes it challenging to tackle factors 
contributing to STIs transmission. (34) The lack of STIs screening might have impacted data 
reporting negatively. HIV transmission will increase when we fail to recognise that its co-
occurrence with STIs will reduce the benefit of ART in prevention and treatment of HIV 
infection. (10)  
      1.2 Study purpose 
Due to the paucity of studies on STI acquisition amongst PLWH in SHR, and Canada at large, 
this study aimed to explore risk factors for STI acquisition in PLWH in SHR. This will be 
addressed in two manuscripts. The first manuscript will explore whether either gender or IDU 
are risk factors for STIs acquisition in the year before and after HIV diagnosis in SHR. Given the 
limitation of SHR health service data on the dependent variable and the limitation of the 
available data on potential risk factors, the second manuscript will involve a systematic review 
and meta- analysis. This review will explore studies addressing risk factors contributing to STI 
acquisition among PLWH in developed countries. The systematic review solely explored STI 
acquisition after HIV diagnosed due to the paucity of literature addressing STI acquisition pre-
HIV diagnosis.  Developed countries were used for the analysis because studies exploring risk 
factors for acquiring STIs in PLWH were also limited in Canada. These countries were 
considered for analysis as their context with respect to STI acquisition amongst PLWH may be 
comparable to Canada.  
Study Objectives: 
1. To explore either gender or IDU as risk factors for STIs acquisition in the year before and 
after HIV diagnosis in SHR.   
2.  To determine if gender is a risk factor for acquiring STIs among PLWH in developed 
countries.  
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3. To determine if IDU is a risk factor for acquiring STIs among PLWH in developed 
countries.  
      1.3 Theoretical perspective and conceptual framework 
Several theoretical perspectives have been created to explain patterns of disease in population 
health. A number of these theories have been applied in HIV/AIDS research, one of which is the 
biomedical model.  
The core of the biomedical theory places emphasis on biological and individual-level factors to 
explain risk of HIV and STI transmission.(35) This model regards social factors as secondary or 
even unimportant in the transmission of HIV and other STIs.(35) Biological factors include 
genetic make-up and susceptibility, disease etiology and mechanism.(35) It regards individuals 
as free beings who are capable of making healthy behavioral choices while ignoring the impact 
of the socio-economic and political environment on risk factors that contributes to the acquisition 
of HIV and other STIs.(35)  As a result, research and preventive programs based on the 
biomedical model are individualistic centered.(35) Data are gathered on individuals living with 
or exposed to HIV and scarcely ever include contextual factors.(35) Prevention programs based 
on this model, such as condom distribution and needle exchange programs are also targeted at 
the individual.(35) 
In contrast, social production of disease theory “conceptualizes determinants of disease 
distribution as economic and social relationships forged by a society's political and economic 
structure”.(36, p.108) These relationships are being channelled via various groups classified by 
socio-economic class, gender, age and ethnicity.(36) The presence of social groups in this 
relationship brings about inequalities amongst the various groups in their health and well-
being.(36) For example, social production of disease theory, explains “how gender-based 
economic inequalities may affect women's ability to determine sexual uses of their bodies” (36, 
p.108), which could lead to their risk of acquiring HIV and other STIs. HIV research based on 
this theory underscores the association between increase STI transmission and groups defined by 
low socio-economic status and racial discrimination. (36) Preventive programs based on this 
theory emphasize social and political policies such as making available employment, low-income 
housing, and affordable education, stating these factors as key to winning the battle of STIs 
transmission.(36) 
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This study recognises the role that both biological/individual factors and contextual factors 
(socio-economic factors) plays in the distribution of health and diseases, but refutes the notion 
that the different factors operate independently in the transmission of disease (HIV and other 
STIs). The researcher believes individuals are greatly impacted by their contextual factors, and 
also that everyone has a role to play in managing their health. In other words, the two theories 
discussed above are mutually inclusive in the explanation of distribution of health and diseases. 
Conceptual framework 
Accordingly, the Proximate-Determinants Framework will guide the study. The conceptual 
framework (CF) was used by Boerma and Weir in 2005, to study distribution and determinants 
of HIV and other STIs. (37) The framework identifies that biomedical and contextual factors are 
both important in the transmission of HIV and other STIs.(37) It also shows important 
determinants to consider in HIV and other STIs transmission, explaining the association between 
these determinants.(37) Emerging evidence emphasizes the role of STIs in HIV transmission. 
This transmission is not affected by individual level factors alone but also by social determinants 
of health such as income, employment, and housing. Unemployed people may lack material 
resources to provide shelter and therefore increase exposure to high-risk behavior and risk of 
HIV infection.  
The framework illustrates three determinants, which are underlying, proximate, and biological 
with health and demography as outcomes. 
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Figure 1.1: Proximate-determinants conceptual framework for factors affecting the risk of 
sexual transmission of HIV. (38) 
Underlying determinants comprise of contextual factors (sociocultural, socioeconomic, 
demography) and intervention programs. (37) In this study, socioeconomic factors will be 
depicted by social quantiles, which is a proxy for income, education and employment in SHR, 
sociocultural by ethnicity, and demography by age and gender. These contextual factors impact 
the proximate determinants leading to exposure and transmission of HIV and other STIs. In order 
for these contextual factors to influence HIV/STI transmission, they are obligated to act on the 
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proximate determinants as illustrated in Figure 1.1. This study will not be focussing on the 
intervention programs. 
Proximate determinants are basically made up of behavioral and biological elements. (37) It 
influences biological determinants, which in turn affects the rate of transmission of HIV and 
other STIs. (37) Behavioral factors such as IDU, MSM, heterosexual practice and sex work will 
be considered in this study but biological factors (VL and biological susceptibility) will be 
excluded from this discussion. 
Biological determinants are factors that influence the reproductive number of an infection, 
regulating HIV and STI prevalence in the population. (37) This subsequently leads to disease and 
death as displayed by the arrows in Figure 1.1. This reproductive number is the product of three 
biological determinants, previously discussed in Section 1.1 where R0 = βDC; β = Probability of 
transmission, D = Duration of infectiousness and C = Measure of number of susceptible 
individuals in contact with infected person. 
A rise or decline in any of these three factors will result in increase or decrease in transmission of 
HIV and other STIs. This research will not explore these determinants nor demographic or 
mortality outcomes. 
Overall, I believe the proximate determinants framework will adequately guide the study. This is 
because it acknowledges both population level factors/underlying determinants (socioeconomic, 
sociocultural, demography) and individual factors/proximate determinants (MSM, IDU, 
heterosexual, STI) as important risk factors in the transmission and co-infection of HIV and 
other STIs. It also centers on the sexual transmission of infection, which is common to both HIV 
and other STIs.  
      1.4 Chapter summary 
This chapter described the rationale of the study and pinpointed the aim and objectives of the 
study. It further described the theoretical perspective and conceptual framework used for the 
study. 
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Chapter 2: Literature review 
This Chapter provides a brief background of HIV and AIDS. It describes the global 
epidemiology of HIV/AIDS. It also discusses epidemiology of HIV/AIDS in Canada, 
Saskatchewan and SHR. Finally, risk factors that may predict STIs acquisition among PLWH 
were discussed. 
      2.1 HIV/AIDS epidemiology 
Globally, over 60 million people are living with HIV and acquired immune deficiency syndrome 
(AIDS).(1-2) Among those affected it is estimated that 42% are females.(1-2) The global HIV 
prevalence  was noted to be 0.8% amongst individuals between ages 15 to 49 years (3), with 
persons under the age of 25 years accounting for 25% of all new infections.(2) The infection has 
claimed about 25 million lives, making HIV/AIDS one of the most complex population health 
problems of the 21st century.(1) Most studies have identified the common mode of transmission 
of HIV as mother to child, blood transfusion, heterosexual, IDU and MSM.(2-5, 6) Although 
about 85% of HIV transmission globally is said to be via heterosexual transmission (2, 6, 7), for 
the purpose of this thesis, modes of transmission will include heterosexual, IDU, and MSM  
Apart from the modes of transmission mentioned above other factors that could contribute to risk 
of HIV transmission include STI, age, gender, ethnicity, occupation, income, education, marital 
status, engagement in sex work, and migrants from endemic countries. (8 - 9) 
2.1.1 Canada 
In Canada, the number of HIV cases diagnosed between 2014 and 2015 has increased from 2,051 
to 2,096.(10) Out of 2,096 HIV cases in 2015, 24.1% were women and 75.9% were men.(10) 
Annually, about 2,300-4,300 new cases of HIV infection occur in the nation.(9) In 2015, HIV 
diagnosed by age group had its highest increase amongst individuals between ages 25-29 and ≥ 
50 years at 11.8% to 15.8% and 21.9% to 23.9% respectively.(10)  Approximately 17.5% of 
Canada’s HIV cases in 2015 was attributed to the Indigenous people.(10) 
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Transmission rate is said to vary in different exposure groups. In 2015, the highest prevalence of 
HIV infection amongst individuals ≥15 years old was attributed to MSM exposure category with 
45.1%, followed by heterosexual (31.9%), IDU (16.3%). (10) 
 
2.1.2 Saskatchewan 
Although, the Canadian incidence rate of HIV has remained stable in the last decade (11-12), 
Saskatchewan has had a significant rise in the number of new cases of HIV since 2003. (13) In 
2015, with a provincial average of 13.9/ 100,000, Saskatchewan had the highest incidence rates 
in the nation.(14) This rate was higher than that of Canada at 5.8/100,000.(14)  
In the same year, 81% of HIV cases in Saskatchewan were from indigenous people. (14) The 
majority of HIV cases were reported in IDU (61%), followed by heterosexual contact (27%).(14) 
HIV cases in the province acquired via IDU exposure group ranged from 49% in 2014 to 79% in 
2009.(14)  
Apart from years 2005 and 2006, males account for most of the HIV cases in the province. (15) 
Sixty -two percent of 2015 HIV cases were males compared to 38% females.(14) The highest 
number of new HIV cases for Saskatchewan in year 2015 was found in SHR, followed by Prince 
Albert, and then Regina Qu’Appelle health region.(14)  
 
2.1.3 Saskatoon Health Region 
Saskatoon Health Region was not excluded from the epidemic and, recorded an incidence rate of 
31.3 per 100,000 people in 2009, which was over four times that of the nation at that time. (4) see 
Figure 2.1 below. The region’s HIV epidemic is also driven by the IDU population, accounting 
for about 66% of HIV infections between 2011 and 2015; this is followed by unsafe heterosexual 
sex. (4)  
The region had 54% of all new cases of infection in the province in 2008. (16) This high 
proportion of newly diagnosed cases might be due to an intensive testing program in the health 
region. From 2011, HIV testing among the high-risk group has risen for both standard and point 
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of care testing at 28% and 12% respectively. (17) Sixteen percent of 600 newly diagnosed cases 
between 2006 and 2015 died as a result of the infection in SHR. (4)  
 
 
Figure 2.1: HIV rates per 100,000 Population, Saskatoon Health Region, Saskatchewan, 
and Canada, 2006 to 2015. (4) 
 
      2.2. Risk factors predicting STIs acquisition among people living with HIV  
Few publications were identified which examined the acquisition of STIs in PLWH. This 
literature review will not attempt to provide a detailed description of the impact of each risk 
factor on acquisition of STI among PLWH. Rather, it will provide an overview of the impact of 
the risk factors, where one exists. The review will draw correlation between the association of 
some of the risk factors with HIV acquisition and that of acquiring other STIs in PLWH. This is 
because more studies have been done in the area of HIV transmission. Furthermore, STIs, HIV 
inclusive are acquired via similar exposure channels. High-risk sexual behavior plays a major 
role in the transmission of both HIV and other STIs. The review will focus on variables that are 
available from SHR health service data for exploration in this research. These include the 
demographic, behavioral, and socioeconomic variables. Details of these variables are available in 
the methodology section. Even though, the risk factors will be discussed separately in this 
review, it is worth noting that these risk groups are not mutually exclusive, an individual could 
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have more than 1 exposure group, resulting in an overlap in the modes of transmission. For 
instance, a person can be a sex worker (SW) and also engage in IDU. 
 2.2.1 Demographic 
The demographic variables that will be discussed in this section focus on biological factors that 
cannot be modified or change. It is different from behavioral factors, which can be altered. 
Gender 
Gender and sex are risk factors that play an important role in the outcome of various health issues 
(18-19) including diagnosis of STI in PLWH. Based on this, current health research usually 
explores these two variables.(18-19) Before 1970s, gender was not considered in health research 
analysis.(19) Even though these variables are now being explored in health research, researchers 
still lack fundamental understanding of sex or gender concepts and as a result these terms are 
used interchangeably or incorrectly.(18-19) While some disciplines such as social sciences are 
more familiar with these concepts, others such as biomedical and clinical health fields are 
not.(18) The two terms have been reported to impact the same health outcome differently, thus, 
their incorrect use will result in the development of inappropriate interventions and policy.(18) 
In order to appropriately use these two terminologies in health research, researchers need to 
clearly understand these two constructs. (18-19) Krieger (2004) stated that “...our science will 
only be as clear and error-free as our thinking". (19, p. 656) For better understanding of these 
concepts, it is of utmost importance to define them.  
Johnson et al. (2009) defined sex as “a multidimensional biological construct that encompasses 
anatomy, physiology, genes, and hormones, which together affect how humans are labelled and 
treated in the world”.(18, p.3) For example, “sex” concept comes into play in HIV heterosexual 
transmission. The European Study Group on heterosexual transmission of HIV in 1992, reported 
that “male to female sexual transmission of HIV is more efficient than female to male 
transmission”. (20, p.7) This implies that females are at higher risk of HIV acquisition compared 
to males and this is due to the variation in their biological and physiological composition. 
Therefore, research based on the concept described above should use “sex” in its analysis and not 
“gender”. 
Sex is mostly denoted by male or female binary in health research. (18) However, research 
related to sex chromosomes showed that apart from the popular XY (male) and XX (female) 
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chromosomes, there are other chromosomal variations. (18) These include XXY, XYY and XO, 
hence binary representation of sex could result in omission of essential information associated 
with the other genetic chromosomes. (18)  
On the other hand, they defined gender as “…a multidimensional social construct that is 
culturally based and historically specific, and thus constantly changing. Gender refers to the 
socially prescribed and experienced dimensions of "femaleness" or "maleness" in a society, and is 
manifested at many levels”.(18, p.3) Societal assessment of males to be superior over females 
shows a structure inequality.(18) The concept of gender is consistently associated with 
socioeconomic and political context on the population level and socioeconomic status at the 
individual level.(18) In HIV research, gender inequality due to socioeconomic status and cultural 
values was reported to have limit the ability of women to negotiate safe sex.(21- 22) Thus, 
increasing the risk of HIV acquisition amongst women as well as STIs acquisition. 
Gender roles are usually determined socially and they arise from gendered experiences, cultural 
values and behavioral norms. (18) The societal conceptions with regard to men or women’s 
behavior (dressing, mannerism and posture) will determine their gender roles. (18) 
Although, sex and gender constructs differ, they are very connected and mutually impact one 
another.(18) For instance, an individual’s secondary sex characteristics (penis/vagina) determine 
how they are addressed by the society.(18) This dictates their gender placement in the society as a 
man or woman or transgender.(18) At the same time, gender also influences sex.(18) Those men 
with high self-perception of masculinity and as such engage in high-risk sports notice a rise in 
their testosterone levels.(18) With this understanding, Prins et al.(2007) suggested "there is no 
difference in the use of the binary variables of sex and gender. The distinction between the two 
terms is usually relevant only when the mechanisms of influence are being studied". (23, p.107) 
The author reasons and agrees with Prins et al. Even though the health service data captured this 
variable using gender, the variable was denoted with male and female and not women and men.  
Globally, male HIV rates are higher than that of the females as documented in section 2.1. The 
same trend has also been documented here in Canada with male HIV rates almost 3 times that of 
the females.(24) The province of Saskatchewan was reported to have the lowest male to female 
HIV ratio (3:2) in the whole of Canada.(25) In SHR, there was a rise in HIV rates for both males 
and females from 2006 to 2009, after which the rates started to drop, but since 2014 the rates are 
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increasing again, see Figure 2.2.(26)  This graph shows that males were more affected than the 
females in SHR.  
 
Figure 2.2 : HIV rates per 100,000 populations by gender, Saskatoon Health Region, 2006 
to 2015. (26) 
In contrast, some studies have recorded a disproportionate burden of infection among females.(21 
- 22, 27) In the last five years, approximately half of all HIV infections worldwide have been 
diagnosed amongst women.(28)  Women were reported to be economically dependent on their 
husbands and partners and as such having little or no control over their body and life (education 
and employment).(21-22) An Irish study showed there is an association between the rising HIV 
prevalence in women and their financial dependency on their sexual partners.(29) This impedes 
their ability to negotiate safe sex thus increasing the risk of acquiring HIV and other STIs.(5,22) 
Some researchers have explored the role of gender inequality in some exposure groups, a major 
one being the IDU. Gender disparity in HIV prevalence among IDU was observed. (30-31) 
Globally, there is increasing concerns about the disproportionate burden of HIV among female 
IDUs. (30) Female IDU were reported to be more highly vulnerable to HIV infection than the 
male IDU.(30-31) 
There are multiple reasons why females who inject drugs may be at higher risk of HIV infection 
compared to their male counterparts.  (20) First and foremost, their male IDU sexual partners 
could introduce them to IDU. (32-33), This impairs their ability to negotiate protected sexual 
intercourse and risk for contracting HIV (32-33), this could also apply to acquisition of other 
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STIs. The iTrack study in Regina highlighted the role of risky sexual behaviors amongst IDUs in 
the transmission of HIV infection. (13) In their study, 88% of female participants had a regular 
sexual partner, however, 70% had never used a condom. (13) Also 24% of these group reported 
having casual sex partners, of which about 8% never used condom. (13) 
In addition, female IDUs may also rely on their male sexual partners for drugs and injections, 
which increases their tendency to share drugs and needles. (30) Those who are not dependent on 
their male partners tend to engage in commercial sex work in order to sustain their drug habit. 
(34-35) 
Another factor that could contribute to the risk of acquiring HIV amongst this group is sexual 
violence. (30) A Canadian study conducted in Vancouver documented a history of sexual 
violence among 68% of female IDUs compared to 19% among males. (30) This finding was 
reinforced by a Russian survey that showed that 21% of male IDUs abused their female IDU 
partners. (30) 
Lastly, there is the high tendency for female IDUs to have male sexual partner who are also 
IDUs.(20) According to the European Study Group on heterosexual transmission of HIV in 1992, 
“male to female sexual transmission of HIV is more efficient than female to male 
transmission”.(20, p.7) This increases the risk of acquiring HIV amongst female IDUs via 
heterosexual contact.(20) We can assume that the role of gender in HIV transmission will be 
similar to that in acquiring other STIs in PLWH.  
The available studies on STIs acquisition in PLWH have varying opinions on which gender is 
more affected. A systematic review carried out by Kalichman and colleagues in 2011, reported 
similarities in the prevalence of STIs in HIV-infected   men and women, at 13.6% and 15.8% 
respectively.(6) On the other hand, several studies recorded that men living with HIV are more at 
risk of acquiring STI.(36- 38) Baffi et al.(2010) reported that men living with HIV are 2.5 times 
more likely to have other STIs than women.(38) This was supported by Manning et al. (2007) 
who observed that HIV-infected men are 1.5 times more at risk of having STI than women.(36) 
The question with regards to which gender is more affected with the burden of STIs in PLWH 
has been inconclusive. This thesis will attempt to shed more light on this in the analysis.  
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 Age 
Age as a biological risk factor impacts several health outcomes (39), thus it will be important to 
discuss its role in acquiring other STIs in PLWH. Age here, will be referred to as age at 
diagnosis. It has been noted that older persons have a higher tendency to poor health status. (39) 
Older people living with HIV are reported to be more at risk of an expedited HIV progression. 
(39-43) HIV depresses their immunity and makes them more susceptible to several opportunistic 
infections (42), therefore increasing their risk of contracting STIs. The relationship between 
aging and HIV advancement is not gender specific (43), that is both males and female are 
affected. It also cuts across various exposure groups such as heterosexuals, MSM, and IDU. (43) 
The association between age and acquiring other STIs in HIV-infected persons vary from one 
study to another. Asavapiriyanont et al. (2013) reported individuals over 25 years as having 
higher STIs prevalence as opposed to those less than 25 years. (44) This finding has been 
supported by various other studies. (37, 45) Hu and colleagues came up with likely reasons that 
could be responsible for this increase among older ages. (37) These include inconsistent use of 
condom, increase in patronizing sex workers, and low uptake of STIs testing. (37) 
On the contrary, Manning et al. (2007) observed that HIV-infected persons under 25 are 3.7 
times more likely than those over 25 years to have STIs. (36) This association was also supported 
by several other studies. (38, 46) 
Despite the fact that the age group of PLWH with other STIs was not clearly defined in studies, 
the author thinks its impact as a biological risk factor cannot be overlooked.  
Ethnicity 
The impact of ethnicity, cultural values and norms cannot be underestimated on health outcomes. 
This is because of the health disparities that have been observed among ethnic minorities in 
developed countries. (30) In North America, ethnic minorities are disproportionately affected by 
HIV and are also more at risk of acquiring the infection. (47-48) This finding was confirmed by 
various studies in USA. (49-52) 
This work will focus its ethnicity discussion on Indigenous people because approximately 70% of 
clients in the SHR health service data used for this research are of First Nations’ ancestry. I will 
also be drawing corollary from other ethnic minorities from other studies.  
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Indigenous peoples’ health has been an area of concern for health sectors in many countries.(53) 
This is due to the low life expectancy experienced by this population, which results from chronic 
diseases, infectious diseases, and limited access to preventive and curative health services.(53) It 
is important to know that physical availability of health services to this group is not enough to 
address their health needs, rather, services that are culturally appropriate.(53) Other factors that 
may contribute to Indigenous peoples’ poor health status include poverty, lack of education, poor 
physical and social environment, and substance abuse.(53-54) All of the aforementioned factors 
increase their susceptibility to being infected with STIs.(53)  
Unfortunately, the burden of HIV infection has increased over the years among the Indigenous 
people in Canada, from about 1% in 1990 to 10.8% in 1999. (55) As at 2011, 8.9% of all PLWH 
are Indigenous people   and the incidence rate in this population the same year was 12.2%, 
despite the fact that this group of people are only 4.3% of Canadian population (54), see Figure 
2.3 below. The infection disproportionately affects males and youth aged 15-29 years.(54) HIV 
rate among Canadian Indigenous people has been reported to be higher than those in other 
countries such as New Zealand and Australia.(54) In 2011, IDU and heterosexual exposure 
accounts for the highest incidence of HIV infections among Indigenous people , with 58% and 
30.2% respectively.(54) In view of this, the prevalence of STIs among HIV-infected Indigenous 
people may be on the high side, especially because these two exposures play a significant role in 
the transmission of HIV and other STIs. 
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Figure 2.3 : Number and percentage of Aboriginal people* among positive HIV tests 2009 
to 2012 (*Data from BC, AB, SK, MB, NS, NB, ON, PEI, NL, NU, NT and YT). (54) 
 
Finding from two Canadian studies among IDU reported an increase in HIV prevalence and 
incidence among Indigenous as compares to non- indigenous people.(53, 55) Studies in United 
States of America observed increase STIs among blacks living with HIV as compared to other 
ethnic group.(38, 46) Baffi et al. (2010) reported that HIV-infected ethnic minorities are 2.2 
times more at risk of STIs   than Caucasians.(38) Another American study showed 92.5% of 
HIV-infected blacks had other STIs.(46) This implies that attention should be paid to health 
needs of ethnic minorities, in our case, Indigenous population.  
Even though, research on this topic with relation to Indigenous people are limited, we can draw 
corollary from the above discussion. 
2.2.2. Behavioral factors 
 Intravenous drug use 
Globally, approximately 15.9 million persons are engaged in IDU out of which 3 million people 
live with HIV. (56-59) Also, about 5 -10% of HIV infection worldwide can be attributed to use of 
intravenous drug. (57-58) In the last few decades, the route of HIV transmission was noted to 
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have transitioned from sexual exposure to illicit drug use, especially IDU. (53) About 25% of 
HIV transmission in North America is linked to IDU.(53)  
In Canada, an estimated 112,900 persons are involved with IDU.(3) With approximately 13.7% 
of all new HIV infections resulting from IDU and about 20% of all HIV infection in Canada 
arising from IDU population.(3, 59) This number was reported to have declined gradually in the 
last two decades.(3) It is worth knowing that majority of the IDU population in Canada are of the 
Indigenous people ethnicity.(3) Amongst women in Canada, about 23% of new HIV cases are 
due to IDU, which almost doubled that of the nation.(59)  
As mentioned previously the HIV epidemic in Saskatchewan is driven by IDU exposure risk, this 
is followed by the heterosexual exposure.(13, 15) Out of 128 HIV cases acquired via IDU in 
2010, 80 were males and 48 females.(15) Even though the percentage of IDU contributing to HIV 
transmission in SHR has decreased from about 75% in 2011 to 64.7% in 2015 (see Figure 2.4), 
the number is still high when compared to the national average of 13.7% in 2011.(3-4)  
 
Figure 2.4: Primary HIV transmission risk trend, Saskatoon Health Region, 2011 to 2015. 
(4) 
 
However, in recent years, various studies have shown the overlap in transmission mode between 
unsafe IDU and sexual behavior. (60) Locally, recent increase in sexually acquired HIV, in the 
face of high IDU, might be pointing to an overlap in the drivers of HIV transmission in the SHR.  
Illicit drug use is usually associated with risky sexual behavior, and thus increasing the 
possibility of transmission of any sexually transmitted disease.(60) It has also been described as a 
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potential modifier of decision-making.(61) The use of these drugs impair proper decision making 
ability which results in various risky sexual behavior such as unprotected sex, having sex with 
multiple and casual partners.(61) Bachmann et al. (2005) concluded in their study that there was 
an association between illicit drug use and sexual risk behavior among PLWH (61), this serves as 
an indicator of their risk of acquiring other STIs. On this note, studies exploring this association 
had reported a high prevalence of STIs amongst HIV-infected IDUs. (61-62) 
It is disappointing to see that the rate of HIV infection acquired via IDU remains on the rise, 
despite adequate HIV preventive strategies (including needle exchange programs (NEP). (64) 
Surprisingly, the success of NEP is still controversial in some parts of the world despite the fact 
that quite a number of scientific papers have established its efficacy. (30, 57-58) 
One factor that could be responsible for this is the continued needle sharing behavior.(29, 63) In 
1988, Vancouver began one of the biggest NEP combined with a street nursing program.(29, 57) 
Although HIV prevalence was stable initially, there was an increase in 1994.(29, 57) Another 
study reported that about forty percent of IDUs still engage in needle sharing activities despite 
availability of NEP.(29) This was reinforced by a Vancouver study which reported that IDUs that 
attended NEP frequently usually become HIV positive.(57) Another factor reported to contribute 
to the rise in HIV prevalence amongst IDUs is inadequate NEP coverage.(57-58) Even though 
NEP is available in 82 countries, with these countries harbouring about 80% of the worlds IDUs, 
yet the HIV prevalence are still high in most of these nations because of inadequate NEP 
coverage.(57-58) 
Several studies have indicated IDUs as high-risk group that expedites the transmission of HIV 
infection to groups with low risk. (33) This transmission was noted to be mostly via engagement 
in high risk behavior which includes both sexual and needle exchange. (33). The Canadian iTrack 
study showed that about 50% of the IDU population in Regina inject with sex partners (13), 
which increases the tendency to share needles. 
 HIV epidemic driven by IDUs is not as simple as it appears. Rather it may be an overlapping 
epidemic between the heterosexual and IDU group driven by complex network of high-risk 
behavior and sexual contact. (30, 33). These high-risk behavior and sexual contact plays an 
important role in the acquisition of other STIs among PLWH. 
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 Men Having Sex with Men  
Several studies amongst MSM reported that there is usually a high tendency to acquire HIV in a 
person with STIs. (64-65) The prevalence of STIs among HIV-infected MSM was documented to 
be high. (45, 66), due to their regular engagement in unprotected anal intercourse with casual and 
multiple partners.  (45, 65), A study conducted by  Mayer et al. in 2012, revealed a high 
prevalence of STIs amongst MSM living with HIV, with 87% coinfection as compared to the 
other modes of exposure.(65) Manning and his colleagues (2007) observed that the odds of HIV-
infected MSM acquiring other STIs was twice that of heterosexuals.(36) These findings were 
supported by several other studies.(30, 45-46, 65) The practice of unprotected insertive and 
receptive anal intercourse among MSM with resultant bruising of the anal canal, has facilitated 
the transmission of STIs in this group.(65) 
Various studies did report the rectal region as harboring asymptomatic gonorrhea and chlamydia 
infections (7, 65–67) and when left untreated serves as a transmission medium for both HIV and 
other STIs. (65) Acquisition of STIs among MSM living with HIV cannot be dealt with, without 
mentioning the effect of the use of illicit drugs. HIV infected MSM, who also have other STIs 
tend to use illicit drug (65), the association between the two was supported by several other 
studies. (68-69). Drug use potentiates high risk sexual behavior and decreases medication 
adherence, thereby increasing the infectiousness of these persons. (65) 
Diaz and his colleagues (2009), in their study, recorded that almost half of HIV-infected MSM 
with STIs diagnosis had casual partners and only about 12% had a steady partner. (45)  It is 
fascinating to know that despite been aware of their positive HIV status, MSM continue to 
engage in risky sexual behavior (45), thereby increasing the rate of being infected with other 
STIs. A high prevalence of STIs in MSM living with HIV as compared to those without STIs was 
reported by several studies in Australia (70), Germany (71), and the USA. (72) 
 Acquiring other STIs in PLWH was noted to disproportionally affect males, particularly MSM. 
(38, 45) This may be attributed to an increase in high-risk sexual behavior engaged in by MSM. 
In a study conducted by Sprenger et al. (2014) they reported that approximately 70% of MSM 
had over 2 or more sexual partners in the last 12 months.(73) However, 21.5% of heterosexual 
men and 10.7% women had over 2 or more sexual partners in the last 12 months.(73) They also 
observed that MSMs had a higher tendency to have casual sexual partners alone or casual and 
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regular partners.(73) These high-risk sexual behavior being practised by HIV- infected MSM 
may predispose them to the risk of acquiring STIs. 
Sex worker  
 It is crucial to know that most research work reflecting the relationship between sex work (SW) 
and acquisition of STIs in PLWH was focussed on women and rarely on men. Sex workers can 
be defined as individuals who exchange sex for money or drugs due to their low socio-economic 
status.(74) Cohan et al. faulted this definition in their study.(75) Cohan and his colleagues felt the 
restriction of sex exchange to money and drugs alone can lead to misclassification of women who 
exchange sex for other valuables as non-sex workers.(75) They assumed that misclassification of 
some women in their study based on the first definition might have led into the distortion in 
association between the presence of STIs in PLWH and female sex worker.(75) The response rate 
in research involving SW are usually low because of stigma associated with the profession, thus 
most research carried out amongst this group make use of snowball sampling and convenient 
samples from STI clinics.(75) 
Women engaged in sex work are usually involved in various high-risk sexual behavior, which 
makes them a key population in the acquisition and transmission of STIs.(44, 75-76) A study 
based in the USA reported a significant association between SW and having STIs in HIV-
infected persons, documenting that HIV-infected participants with other STIs are almost 3 times 
more likely to be engaged in SW than those without STI.(46) In a study carried out among MSM, 
being a sex worker was associated with the risk of acquiring both HIV and STI.(45) Similar 
observation was noted in other studies.(7-78) 
Injection drug use was also documented by several studies as popular among these women. (75-
76) Some of the studies recorded the prevalence of IDU in SW to be 58% in Yunnan, China (79), 
51% in seven United States cities (80), 56% and 65% in Vancouver and Montreal, Canada, 
respectively (81-82), 71% in Glasgow, Scotland (83), and 82% in Amsterdam, Netherlands. (74)  
 It is worth knowing that SW financial dependency on their clients in many instances predispose 
them to have little or no control over their body. (76) As such, they may be unable to negotiate 
condom use and use of intravenous drugs. (76) They may also be subjected to sexual violence 
from their customers, sexual or injection partners, hotel managers, and police. (76) These factors 
increase their risk of acquiring STIs. 
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 Heterosexual 
In the last few years the incidence of STI has risen significantly among heterosexual PLWH in 
high income countries.  (66) This increase may be due to a rise in unsafe sexual practices, which 
exposes them to being infected by STIs. (66 In a study among commercial sex worker in 
Amsterdam, 30% of their participant tested positive for HIV. (74) The majority of these HIV 
positive participants self -identified as heterosexual and only one person was an IDU.  (74) Des 
Jarlais et al. (2014) found an increase in HIV prevalence from 8% to 16% between 1995 to 1999 
and 2005 to 2011in a US study.(84) This study was conducted amongst non-injecting drug users 
and 95% of this group  were heterosexuals.(84) They also found a higher prevalence of herpes 
simplex virus 2 among PLWH compared to those without HIV.(84) Another US study among 
PLWHA reported that about 43% of 207 PLWHA  diagnosed with chlamydia practised  
heterosexual sex , while  38% were MSM.(36) On the contrary, a Netherlands study amongst 245 
heterosexual HIV patients recorded only 1.6% of their participants with other STIs .(85) The 
findings in these studies might be due to the level of high risk sexual behaviour among this 
population. The higher the level of high risk behaviour, the higher the risk of HIV or other STIs 
transmission. (36,74,84,85)  
In SHR, transmission risk among heterosexual persons was reported to have increased from 13% 
in 2009 to 20.9% in 2013. (86) A health region report in 2015 showed an increase of 36% in HIV 
cases from 2014 to 2015, attributing the rise to sexual transmission. (63) Again, an increase in 
sexual HIV transmission will reflect increased risk of STI transmission. 
Sex with confirmed /suspected PLWH 
The act of having sex with individuals that have laboratory diagnosis of HIV or suspected to have 
HIV, due to the presence of some clinical features, was categorised as one of the high-risk sexual 
behavior.(44, 46, 66) Hague et al. (2011) mentioned that the diagnosis of STIs in PLWH implies 
ongoing sexual risk behavior after being diagnosed with HIV.(46) They found an increase in 
STIs amongst African-Americans living with HIV; these participants were MSM less than 25 
years.(46) This increase was attributable to their high-risk sexual behavior after been diagnosed 
with HIV and other STIs.(46)  Mayer et al. seconded this finding.(65) 
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2.2.3. Socioeconomic factors  
The majority of HIV and other STIs preventive programs are targeted at individual level 
behavioral changes, while the role of social and economic factors in STIs transmission at the 
population level is being totally ignored.(87) Social inequalities in health have been well 
established in Canada(90), with various studies reporting a significant association between 
socioeconomic status (SES) of an individual and their health outcomes.(89-90) This association 
was observed all over Canada, though it varies from one region to another. The Western regions 
(Prairies and British Columbia) “premature mortality gaps according to a Deprivation Index” was 
higher than that in other regions. (88, p.470) Socioeconomic factors have also been noted to be 
essential in explaining infectious disease pattern and an association was observed between HIV 
infection and social and material deprivation.  (91) HIV is described as a disease of marginalized 
and impoverished people or nations. (91)  
In recent times, health status is assessed objectively and subjectively using clinical indicators. 
(92) A good example of an approach of assessing health subjectively is the use of health-related 
quality of life (HRQOL), which is associated with the socioeconomic contextual factors that 
affect human health.(92) 
Ruiz Perez et al. (2004), in their study among PLWH, noted a significant association between 
socioeconomic factors (being employed, social support) and better physical and mental health 
status. (92) It is worth noting that mental status of an individual impacts their decision-making 
ability, which subsequently affects their engagement in high risk sexual behavior as previously 
discussed in Section 2.3.2. Several studies have characterized SES using education, income and 
employment as its proxy measure (87,93), but some others consider gender inequality as one of 
the proxy measures. (94) Saskatoon Health Region uses the Deprivation Index as a proxy 
measure of SES. This index will be discussed in detail in the methodology section of Chapter 3. 
 Employment/Income 
Unemployment has been identified as a predictor of both morbidity and mortality in human 
society.(95)  Having a job plays a primary role in the sustenance of income level and availability 
of housing, particularly among individuals with chronic diseases such as HIV.(95) Previous 
studies on unemployment rates among PLWH recorded the rate as ranged from 45% to 65%.(96-
101) Unemployment in this study was reported to affect females, older age, individuals with low 
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education, immigrants, and IDU.(94) Dray-Spira et al. (2007) found that the employment rate 
was 75% higher among the general population compared to PLWH before 1994 and 91% higher 
after 1994.(95) Unemployment was recorded more among persons with low education.(95) 
Shortly before the year 2000, low SES was reported by a review of Canadian evidence as a 
relevant predictor in the rise in HIV death having controlled for age, disease stage and, access to 
health care.(87) This discovery was backed up by a British Columbia study, early in 2000’s (93), 
this study measured SES using neighbourhood income.(93) Their finding was associated to 
inequitable access to triple ART, which was available to high SES.(93) The role of SES in the 
transmission of HIV has been viewed from severally angles, having different factors implicated.  
Employment plays a primary role in the availability of stable housing. The effect of unstable 
housing on the transmission of HIV was widely underscored and should not be overlooked. 
Living condition was classified by World Health Organization as a pivotal health 
determinant.(102) With this in mind several studies were carried out to determine the relationship 
between poor housing condition and unfavourable health outcomes.(102) The majority of these 
studies identified a significant association between these two variables.(103-105) A Canadian 
study among young homeless women found that these women are 10 times more likely to die 
when compared to other women in the general population.(102) 
In HIV research, unstable housing condition was related to high-risk behavior such as IDU, this 
subsequently leads to risky sexual behaviors (102), predisposing these individuals to HIV and 
other STIs. Corneil and colleagues (2004), in a study conducted in Vancouver among IDUs, 
found unstable housing was related to several HIV risk behavior such as sharing of needles and 
sex trade. (102) Their analysis found a significant increase in HIV rate in individuals who live in 
unstable housing (see Figure 2.5). (102) 
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Figure 2.5: Cumulative probability of HIV infection among IDU stratified by housing status 
at baseline. (102) 
 
In most instances women are more likely to be categorised in the low SES globally. (22) Some of 
them were observed to engage in sex trade due to their low SES. (22) Most studies documented 
that their financial disempowerment could have resulted from low or no education and 
unemployment. (27) Considering the fact that these women are economically dependent on their 
clients and partners, their opinion on safe sexual practice is usually disregarded (22- 27, 9496), 
and this increases their risk of acquiring HV and other STIs. (22) 
Some other studies reported that low SES indirectly impacts the transmission of HIV through 
inadequate nutrition and micronutrients.(106, -107) The likelihood of poor nutrition among 
PLWH was attributed to their poor financial status.(106, -107) Certain factors that were suspected 
to have played a role in the malnourishment observed in PLWH include IDU, alcohol use, 
inadequate financial resource to sustain necessary dietary requirement, progression of the disease, 
and side effect from the use of ART.(106) Though the study could not say for sure if the poor 
nutritional state was independently from each of these factors or whether it was more of a 
collective effect of all of them.(106) 
In the presence of poor nutrition and low micronutrient intake the immune system is impaired 
and vagina epithelium is also damaged, thereby increasing the risk of heterosexual HIV 
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transmission. (94, 107-108) Transmission of STI might also increase as a result of heterosexual 
exposure and secondly through breakdown in vagina epithelium. A study reported a higher life 
expectancy in HIV-infected individuals with better SES, presumably due to adequate nutritional 
intake which improves with high SES. (107) 
Education 
A study conducted in Spain reported that PLWH with no or low education are 3.4 times more 
likely to acquire other STIs as compares to those with high education level.(45) Zhu et al. (2011) 
seconded the findings when they recorded that the odds of persons with lower education 
acquiring HIV and other STIs was 7.4 times more than for individual with higher education.( 
109)  Having reflected on the effect of low SES in HIV and other STIs transmission, gender 
inequality might be contributing to their association, no wonder it is considered as one of the 
proxy measure of SES.(94) 
Taking a peep into Saskatchewan’s women status in terms of income, employment and 
education, they might not be left out of gender inequality when compared to the male counterpart. 
(110) Figure 2.6 illustrate employment rate of males and females from 1981 and 2009 in 
Saskatchewan. (110) It is obvious from the graph that the males are more employed compared to 
females. More women in Saskatchewan earn between   $10/hour to $19.99/hour, while men are 
paid over $20/hour (110), this could result into inequality in income. 
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Figure 2.6: Employment rates in Saskatchewan by sex and age group, 1981 to 2009. (110) 
 
Even though, more females were reported to have attended university, as evidence by the 
graduation rate (62%) for first degree in 2008 (113), women’s education is still limited to certain 
courses.(112) The number of females admitted to some university programs such as architecture 
and engineering is very limited.(111-112) Seventy- eight percent of graduates from these 
programs were males in 2008.(111) The high rate for male graduates was also noticed in 
mathematics, computer and information sciences programs, having 70% of graduates to be 
males.(111) 
 This literature review can not draw a clear conclusion regarding the variables explored in this 
Chapter. Hopefully, the next 2 Chapters will be able to shed light on the relationship between 
these variables and acquisition of STIs in PLWH.  
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Chapter 3: Manuscript 1: Exploring risk factors for sexually transmitted infections in 
people living with HIV in Saskatoon Health Region 
      3.1 Abstract 
Background: The diagnosis of other STIs in PLWH suggest the possibility that PLWH are 
putting non-infected individuals at risk of HIV infection. Thus, identification of subgroups of 
PLWH at risk of STI acquisition is essential to guide intervention programs, such as to prevent 
further transmission of HIV and other STIs. Studies exploring risk factors for STI acquisition in 
HIV are not available in SHR, and limited in Canada overall.  
Objective: To explore whether either gender or IDU are risk factors for STI acquisition in the 
year before and after HIV diagnosis in SHR. 
Methods: This study examined SHR health services data on PLWH during the years 2009 to 
2014. Twenty-two PLWH with STIs diagnosis within a year before and after HIV diagnosis were 
compared to one hundred and thirty three PLWH without STI diagnosis for variables potentially 
associated with STI acquisition in HIV. 
Result: There was a bivariate association between the potential risk factors, gender, age, sex 
worker, and MSM and the risk  for STI acquisition in the year before and after HIV diagnosis in 
SHR, at p-value <0.20.  Multivariable analysis showed an association with marginal statistical  
significance between female (OR: 4.99; CI: 0.89 -27.3) and the risk for STI acquisition in the 
year before and after HIV diagnosis in SHR. There was also a signifcant association between sex 
work (OR: 5.0; CI: 1.03 -24.6) and the risk for STI acquisition in PLWH during this period in 
SHR. No association was observed between IDU and the risk for STI acquisition in the year 
before and after HIV diagnosis in SHR (OR: 0.2; CI: 0.03 -1.2). No interaction was observed 
between the variables. 
Conclusion: The acquisition of STI in HIV shows that PLWH continuously engage in high-risk 
behavior, even after HIV diagnosis. To prevent or reduce the acquisition of these STIs in HIV 
public health practitioners should carefully select programs to address these risky behaviors.
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3.2 Introduction 
Studies have shown an increased risk of HIV transmission when the infection co-exists with 
other STIs, especially in the presence of inflammation and ulcer. (1-3) Even though coexistence 
between HIV and STIs is said to affect the risk of transmission of both diseases (4), much work 
has not been done on the possibility of acquiring STIs after an HIV infection as compared to the 
risk of acquiring HIV in a person with STI. The diagnosis of other STIs in PLWH suggest the 
possibility that PLWH are increasing the risk of HIV infection in non-infected individuals. (5) 
This calls for further preventive measures in this population, therefore identification of 
subgroups of PLWH at risk of acquiring other STIs is essential to guide intervention 
programs.(5) 
In SHR, data for HIV and other STIs are captured separately. Human immunodeficiency virus 
and other STIs coexistence data can only be made available when the region’s HIV data is linked 
to that of other STIs. Hence, a separate overview on HIV and other STI with respect to gender 
and IDU will be provided in this section.   
The most common reportable STI in Canada is chlamydia infection, followed by Neisseria 
gonorrhea, and syphilis infection.(6, 7) According to the Public Health Agency of Canada 
(PHAC), STI rates have increased over the years as seen in Table 3.1 below.(7) Chlamydia 
infection affects more women between 20-24 years, while gonorrhoea affects more men than 
women, aged 15-29 years.(6, 7) 
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Table 3.1: Sexual transmitted infection rate over 10 years from 2002-2011. (7) 
Year Chlamydia Gonorrhea Infectious Syphilis 
Cases Rates Cases Rates Cases Rates 
2002 56,266 179.5 7,365 23.5 482 1.5 
2010 93,329 273.7 10,743 31.5 1,698 5.0 
2011 100,044 290.4 11,397 33.1 1,757 5.1 
 
Sexually transmitted infections have also been on the rise in SHR.(8) Although the rates are 
dropping in the recent years, they are still high compared to the national average with chlamydia, 
gonorrhoea and syphilis having 412.9, 61.5, 1.2 per 100,000 respectively in 2013.(8) see Figure 
3.1 for chlamydia rates in Canada, Saskatchewan, and SHR. 
 
Figure 3.1: Chlamydia rate per 100,000 populations, Saskatoon Health Region, 
Saskatchewan, and Canada, 2004 to 2013. (8) 
 
In SHR chlamydia infection is the most commonly reported STI, with the infection affecting 
more females than males. This is similar to the national chlamydia distribution.(8) The infection 
majorly affects young women ages 15 to 24 years and men, ages 20 to 29 years.(8) This is 
followed by gonococcal infection, which often co-infects with chlamydia.(8) Contrary to 
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chlamydial gender distribution, gonorrhea cases are almost the same for both males and females, 
although males are more likely to be symptomatic.(8) The age distribution for gonococcal 
infection is similar to that for chlamydia infection.(8) Saskatoon Health Region’s syphilis rates 
were reported to be lower than both national and provincial rates.(8) The infection was noted to 
disproportionately affect more men than women, with the majority of the affected men being less 
than thirty years of age.(8) These infections were reported to be transmitted via unprotected 
sexual intercourse.(8) Discussion of the independent relationship of gender or IDU with HIV can 
be found in Section 2.1 (HIV/AIDS Epidemiology).  More information can also be found in 
Sections 2.3.1 (Gender) and 2.3.2 (IDU).  
It has been documented that the use of injection drugs is affiliated with risky sexual behavior, 
and subsequently the risk of acquiring STIs in an individual infected with HIV.(9) Injection drug 
use impairs decision making with regard to sexual behavior, hence, the increased tendency to 
acquire STI.(9, 10) With IDU contributing over 70% of HIV transmission in SHR (11), it is 
important to assess if this risk factor also contributes to the risk of acquiring other STIs in 
PLWH. Literature search did not reveal any studies exploring risk factors for acquiring STIs 
among PLWH in SHR. Studies examining this association were also limited in Canada. Note that 
the risk for acquiring other STIs in HIV in our study implies risk factors for STI acquisition in 
the year before and after HIV diagnosis .This study explored whether either gender or IDU are 
risk factors for STIs acquisition in the year before and after HIV diagnosis in SHR. Other STIs in 
this study were limited to chlamydia trachomatis, gonococcal infections, and syphilis.   
      3.3 Methods 
3.3.1 Study design 
Saskatoon Health Region health services data on PLWH during the years 2009 to 2014 was used 
for this study. HIV positive individuals with a record of other STIs and HIV positive individuals 
with no record of STIs were compared for variables potentially associated with STIs acquisition 
in PLWH.  
3.3.2 Setting and population 
Saskatoon Health Region is situated in the central part of the province of Saskatchewan; see 
Figure 3.2 (12), and it is the largest health region in the province.(13) The region’s population 
accounts for 30% of the province with approximately 350,000 people in 2014.(13) In 2011, 
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people of Indigenous people  descent comprised of 10% of the health region’s population, and 
10% of the population were made up of other ethnic minorities.(14) The study population 
includes HIV-infected patients during the years 2009 to 2014 as recorded by the Public Health 
Observatory (PHO). 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Map of Saskatchewan (12) 
 
3.3.3 Operational and ethics approval 
Ethics approval and Operational approval were obtained from the University of Saskatchewan 
Behavioral Research Ethics Board and SHR respectively. 
3.3.4 Data  
This public health dataset consisted of diagnosed HIV cases and individuals who tested positive 
for an STI. It reports positive laboratory results of reportable diseases notified by physicians to 
public health in SHR. Data collection was facilitated by the HIV case reporting form (See 
appendix A) .The HIV data were directly linked to other STIs using Personal health number 
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(PHN), while its linkage to deprivation quintile used encounter identification number. These data 
were retrieved from Integrated Public Health Information System (iPHIS).  
3.3.5 Inclusion and exclusion criteria 
All HIV positive cases reported to PHO from January 1, 2009 to August 15, 2014 were eligible 
to be included in the study. However, participants used for the analysis were  limited to reported 
HIV-infected patients with and without other STIs in the year before and after HIV diagnosis. 
This study cohort was divided into two groups, the first group had STIs, while the second group 
did not. The time frame was used in order to equalize the opportunity for both groups to present 
with STIs. The time frame was also used  because HIV and other reportable STI records do not 
follow  patients when they move from one Regional Health Authority to another, and this could 
affect the  accuracy for selecting controls for the study. HIV cases prior to 2009 were not used 
because they were reported non-nominally, without name or health services number identifier 
thus making it difficult to link to other nominally reported STIs. Inclusion and exclusion criteria 
are summarized below.  
Inclusion criteria: 
(a) HIV positive patients with at least one other STI* in the year before and after HIV 
diagnosis that were reported to PHO of SHR between 2009 and 2014.  
(b) HIV positive patients with no record of other STI* either in the year before and after HIV 
diagnosis and outside this period that were reported to PHO of SHR between 2009 and 
2014 . 
Exclusion criteria 
(a) HIV cases reported prior to 2009 or after 2014. 
Note: STI*- newly reported chlamydia, gonorrhea, or syphilis. 
3.3.6 Variables 
These variables are mandated to be collected by the regions under the Public Health Act in 
Saskatchewan. See description of collected variables below. 
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Gender : This variable was obtained from the HIV case report form and laboratory results 
detailing STI diagnosis. In the case report it was recorded as male, female and others. The first 
two options were frequently selected and will be used in this analysis. 
Age at diagnosis : This was calculated by subtracting patient date of birth recorded in either the 
HIV case reporting form or STI laboratory result, from the date of HIV diagnosis. Age in this 
data set ranges from 18 -73 years, this was grouped into 3 categories: <30 years, 30-39 years and 
≥ 40 years. 
Ethnicity : The variable was collected from the HIV case reporting form. This variable is made 
up of several ethnicities (see appendix B), which were self-declared. However, it was re-
categorised into Indigenous people  and non- Indigenous people  because of the limited data set. 
HIV Exposures Categories : Risk factors for HIV transmission were obtained from the HIV case 
reporting form. In Canada, primary exposure risk for HIV is assigned to an individual with 
multiple risks. This shows the most likely route of transmission. Primary risk uses a hierarchy of 
risk to assign probable exposure category, with the aid of ranking (see Appendix C for complete 
list of all exposure categories , their interpretation, and 
ranking). These exposure risk were self-reported. 
Deprivation Quintile : A Deprivation Index (DI) is a tool used to monitor socio-economic 
inequalities in health.(15) Deprivation quintile was used as a proxy for income and education 
level in this study. The index was derived from the postal code, making use of the total national 
Deprivation Index.(15) The index has been available since 1991(16), but the most generally used 
version in Canada was developed in Québec in 1999.(15) This has been used in Québec for the 
last 10 years.(15) The Deprivation Index was developed using data from 2006 census and robust 
statistical methods.(15, 16) The DI has two components, the material and social components, 
which are combined to calculate the overall Deprivation Score (Total deprivation).(15, 16) See 
Figure 3.3 below. 
The variables included in the material component of the Deprivation Index are:  
• The proportion of people aged 15 years and older with no high school diploma  
•  The employment to population ratio of people aged 15 years and older 
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•  The average income of people aged 15 years and older  
The variables included in the social component of the Deprivation Index are:  
• The proportion of individuals aged 15 years and older living alone  
• The proportion of individuals aged 15 years and older who are separated, divorced or 
widowed  
• The proportion of single-parent families  
 
Figure 3.3: Combining material and social deprivation quintiles into total deprivation. (15) 
 
Where Quintile 1 (Q1) is the most affluent quintile and Quintile 5 (Q5) is the least affluent 
quintile. 
“The Deprivation Index is calculated at the dissemination area (DA) level. The DA is the lowest 
geographic area, for which census data are available.(16) It is made up of one or more adjacent 
dissemination blocks (16), and its population ranges between 400 -700 people.(15) Principal 
Component Analysis for each dissemination area is used to determine the factor scores using 
social and material components.(15) The DA are then ranked according to their factor scores and 
designated to a quintile.(16) Note that in SHR, approximately 20% of the population was 
covered.(16) Scantly populated DAs were not classified.(16) Other DAs not classified include 
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those with high volume of collective households or institutionalized persons and those 
established on First Nations reserves.(16) 
The PHO tagged these variables in their data set as: 
➢ QMATLOC = local material deprivation quintile  
➢  QSOCLOC = local social quintile 
➢ TOTDEPLOC = total local (combination of material and social scores) (16). 
The quantiles were re-categorised into Not-deprived (Q1-Q3) and Deprived (Q4-Q5), because of 
the limited data set. 
3.3.7 Variable selection  
The independent variables available for analysis were summarized in Table 3.2 below. However, 
not all of these variables were considered for the study analysis for a number of reasons. Marital 
status was not explored because it was 85% incomplete. Number of sexual contacts was also 
excluded from the analysis because the contact database does not contain a unique identifier, 
which allows direct linkage of HIV data to contact data. The contact database also does not have 
enough nominal identifiers to make a probabilistic link. Lastly, immigrant status was not 
included in the analysis because only one HIV-infected participants without STIs was 
documented. Again, it is worth noting that cases of previously reported HIV, diagnosed in 
another country, other provinces in Canada or Regional Health Authority, were not reported as 
new cases of HIV in SHR. 
3.3.8 Dependent variables 
  The dependent variable of interest was a dichotomous indicator of acquisition of other 
STIs in the year before and after HIV diagnosis (Yes/No).  
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Table 3.2: Variables available in database 
Category Variable Description Type 
Demographics Gender 
Age 
Ethnicity 
Female, Male or Other 
At Diagnosis 
White, First Nations, 
Métis, African, Asian, 
Other 
Categorical 
Continuous 
Categorical 
HIV Risk Factors Heterosexual, 
Heterosexual sex with 
IVdruguser, 
Heterosexual sex with 
bisexual male, 
Heterosexual sex with 
person from endemic 
country, Born in 
endemic country, if yes, 
which country, 
Heterosexual sex with 
person with HIV/AIDS 
(diagnosed or 
suspected),Injection 
non-prescription drug 
user, Received blood or 
blood components after 
1985, 
Occupational 
exposure,Other medical 
Category of HIV 
Exposure 
Categorical 
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exposure, 
Other non-medical 
exposure 
(tattoo, acupuncture), 
Mother-to-child-
transmission 
Sex Trade Worker, 
Sex with a partner of the 
same sex, 
Deprivation Quantile Material deprivation 
quantiles (QMATLOC) 
Social deprivation, 
quantiles(QSOCLOC), 
Total deprivation 
quantiles 
(TOTDEPLOC) 
Categories of 
deprivation quantiles  
Categorical 
Encounter Date Date  Date of first encounter Continuous 
 
Variables were chosen after considering their potential influence in the risk for acquisition of 
STIs in PLWH from literature review. Table 3.3 below shows the variables used in our analysis.  
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Table 3.3: Variables used in the statistical analysis 
Category Variable Description Type 
Demographics Gender 
 
Age  
Ethnicity 
 
 
Female, Male or 
Other 
At Diagnosis 
White, First Nations, 
Métis, African, 
Asian, Other 
Categorical 
 
Categorical 
 
Categorical 
HIV Risk Factors Heterosexual, 
Heterosexual sex with 
person 
with HIV/AIDS 
(diagnosed or 
suspected), 
Injection non-
prescription drug 
user, 
Sex Trade Worker, 
Sex with a partner of the 
same sex, 
Category of HIV 
Exposure 
Categorical 
Deprivation Quantile Material deprivation 
quantiles (QMATLOC) 
Social deprivation, 
quantiles(QSOCLOC), 
Total deprivation 
quantiles 
(TOTDEPLOC) 
Categories of 
deprivation quantiles  
Categorical 
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3.3.9 Data Analysis 
Initially data cleaning and management was conducted. During this process distribution of 
variables was done and variables of interest were determined with the aid of Statistical Package 
for the Social Sciences (SPSS) Statistics 20. Descriptive characteristics were summarized using 
frequencies and percentages. Association and level of significance between independent 
variables demographic (Gender, ethnicity, age), behavioral characteristics (IDU, MSM, 
heterosexual, sex work) and the risk for STI acquisition  among PLWH were examined with 
bivariate logistic regression and Pearson chi-square. The level of significance to enter the 
multivariable model from the  bivariate logistic regression was based on p-value <0.20. 
Multivariable logistic regression at p-value < 0.05, was finally conducted, based on the Hosmer 
and Lemeshow purposeful forward selection criteria, on all significant variables in the bivariate 
analysis. This assessed their independent contribution to the risk for STIs acquisition in PLWH, 
after adjusting for other risk factors. Interaction between variables were also examined. 
Confounding was assessed for by using logistic regression. In addition, variables (counfounders) 
were also determined based on their clinical importance and the effect of their removal on the 
Beta coefficient  ( ≥ 20%) . Three models were constructed, the first and second model explored 
gender and IDU respectively, in addition to independent variables qualified for the multivariable 
model. The third model had the two risk factors of interest (IDU and gender) and other 
independent variables qualified for the multivariable model.  
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3.4 Results  
Three hundred and thirty nine (339) newly reported HIV clients were available for inclusion in 
our study , 71 of which had other STIs in PLWH. Of these, only 22 acquired  other STIs in the 
year before and after HIV diagnosis, rendering the remaining 49 clients inelligible for 
comparison because they had STIs outside the window period of one year before and after HIV 
diagnosis. 
The remaining 268 of the 339 HIV clients were elligible as cases without STIs, however 92 of 
these clients had missing data on history of  STIs, leaving us with only 176. Of these 176 clients, 
18 had history of previous STI, 23 answered “unknown” to history of previous STI and 2 
answered “not asked” to history of previous STI.  Thus, 43 clients were excluded from the cases 
without STIs, leaving us with 133 clients.  Analysis was conducted on the 155 participants who 
were eligible for the study. Total occurrence of STIs among the study cases were 23 chlamydia, 
9 cases of gonococcal infection, and 0 cases of syphilis within a year before and after HIV 
diagnosis. See figure 3.4 below for the summary of data set. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Summary of data set 
HIV and STI lab 
diagnosis 
N= 71 
HIV no STI 
diagnosis 
N=268 
HIV and STI lab 
diagnosis 
 (+/- 1 year) 
N= 22 
HIV no STI diagnosis 
(+/- 1 year and outside 1 
year) 
N= 133 
Study Data Set 
N=155 
Female =51 
Male=104 
Missing=0 
Age 
18-29 =13 
30-39=80 
≥40=62 
Missing=0 
 
Sex worker= 18 
Non-sex worker=56 
Missing= 
81 
MSM=14 
Non-MSM=70 
Missing=71 
HIV diagnosed in 
study period  
(2009-2014) 
N=339  
Had STIs 
outside +/-
1 year =49 
Missing data on STIs 
hx=92 
Self-reported hx of 
STIs/unknown=43 
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3.4.1 Study population characteristics 
Table 3.4. Summarizes the demographic, behavioral and social characteristics of the study 
population. A total of 155 PLWH met the inclusion criteria for the study; 22 with STIs and 133 
without. There is higher percentage of females and young individuals between ages 18 and 29 
years among PLWH with STIs (within a year before and after HIV diagnosis) compared to 
PLWH without STIs. 
In terms of behavioral charcateristic, PLWH with STIs had a greater proportion of sex worker, 
andMSM compared to PLWH without STIs. Figure 3.5 illustrate that some of our participants 
have overlapping risk factors.  
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Table 3.4: Baseline characteristics (N=155) 
Variables HIV and STI 
(YES=1) 
N (%) 
HIV and  STI 
(NO=0) 
N (%) 
P-value 
Gender 
Female 
Male 
Missing/unknown 
 
14 (63.6%) 
8 (36.4%) 
0 
 
37 (27.8%) 
96 (72.2%) 
0 
 
<0.001 
Injection drug use 
Yes 
No 
Missing/unknown  
 
14 (63.6%) 
8 (36.4%) 
0 
 
92 (73.2%) 
34 (26.8%) 
7 
 
0.37 
Age 
18-29 
30-39 
≥40 
Missing/unknown  
 
6 (27.3%) 
12 (54.5%) 
4 (18.2%) 
0 
 
7 (5.3%) 
68 (51.1%) 
58 (43.6%) 
0 
 
<0.001 
Ethnicity 
Indigenous people  
Non Indigenous people  
Missing/unknown  
 
15 (71.4%) 
6 (28.6%) 
1 
 
86 (69.9%) 
37 (30.1%) 
9 
 
0.89 
Sex Worker 
Yes 
No 
Missing/unknown  
 
6 (54.5%) 
5 (45.5%) 
11 
 
12 (19%) 
51 (81%) 
70 
 
0.01 
Men having sex with  men 
Yes 
No 
Missing/unknown  
 
4 (33.3%) 
8 (66.7%) 
10 
 
10 (13.9%) 
62 (86.1%) 
61 
 
0.09 
Sex with confirmed HIV 
Yes 
No 
Missing/unknown  
 
8 (53.3%) 
7 (46.7%) 
7 
 
42 (40.0%) 
63 (60.0%) 
28 
 
0.33 
Heterosexualcontact no 
other risk 
Yes 
No 
Missing/unknown  
 
 
12 (92.3%) 
1 (7.7%) 
9 
 
 
65 (86.7%) 
10 (13.3%) 
58 
 
 
0.57 
 Material deprivation 
quantiles 
Not Deprived(Q1-Q3) 
Deprived(Q4-Q5) 
 
 
6 (27.3%) 
16 (72.7%) 
 
 
32(29.1%) 
78(70.9%) 
 
 
0.86 
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Missing/unknown  0 23 
Social deprivation quantiles 
 
Not Deprived(Q1-Q3) 
Deprived(Q4-Q5) 
Missing/unknown  
 
 
8 (36.4%) 
14(63.6%) 
0 
 
 
31(28.2%) 
79(71.8%) 
23 
 
 
0.44 
Total deprivation quantiles 
 
Not Deprived(Q1-Q3) 
Deprived(Q4-Q5) 
Missing/unknown  
 
 
7  (31.8%) 
15 (68%) 
0 
 
 
31(28.2%) 
79 (71.8%) 
23 
 
 
0.73 
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Figure 3.5: Overlap between Indigenous people  ethnicity, IDU, and STI (N=155)1 
 
 
 
 
 
                                                          
1 One participant had missing data for both IDU and Indigenous people  
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3.4.2 Risk factors for acquisition of other STIs within a year before and after HIV diagnosis 
Table 3.5 shows a summary of bivariate analysis between each independent variable and STI 
acquisition in the year before and after HIV diagnosis. An association with the risk  for STI 
acquisition was observed for:  female gender, age ,sex work, and MSM, even though their 
confidence intervals were wide. The wide confidence intervals could have resulted from the 
small sample size, and this could be narrowed if the sample size was increased.  Other variables 
such as IDU, ethnicity, and deprivation quantiles were not associated with the risk  for STI 
acquisition in the year before and after HIV diagnosis.  
Gender, age, sex work, and MSM were chosen for inclusion in the multivariable model based on 
p-value <0.20. Injection drug use was added to this model because it is one of the two risk 
factors of interest to be explored as contributing to the risk for STI acquisition in PLWH.  
Table 3.6 and 3.7 show independent multivariable analysis with “gender” and “IDU” 
respectively.  Table 3.8 shows multivariable analysis with all the variables qualified for the final 
model, however because of collinearity observed between gender and MSM , MSM was taken 
out of the final model. The multivariable analysis showed an association between female gender 
(OR 4.9), sex work (OR 5.0) and the risk  for STI acquisition in the year before and after HIV 
diagnosis in SHR (See Table 3.8). Contrary to our expectation, IDU was not associated with the 
risk  for STI acquisition in the year before and after HIV diagnosis (OR 0.20). No interaction 
was detected in the final multivariable models.  
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Table 3.5: Bivariate analysis of factors associated with STI acquisition in the year before 
and after HIV diagnosis (N=155) 
Variables *OR (95%CI) P-value 
Gender 
Male 
Female 
 
1.0 
4.5 (1.76 - 11.7) 
 
 
<0.001 
Intravenous Drug User 
No 
Yes 
 
1.0 
0.7 (0.25-1.68) 
 
 
0.37 
Age (years) 
< 30 
30–39 
≥ 40 
 
1.0 
0.2 (0.07–0.62) 
0.1 (0.04–0.43) 
 
 
0.01 
<0.001 
Ethnicity 
Indigenous people  
Non- Indigenous people  
 
1.0 
0.9 (0.34-2.58) 
 
 
0.89 
Sex Worker 
No 
Yes 
 
1.0 
5.1 (1.33- 19.5) 
 
 
0.02 
Heterosexual  
No 
Yes 
 
1.0 
1.9 (0.22-15.8) 
 
 
0.58 
Men having  sex with 
men 
No 
Yes 
 
 
1.0 
3.1 (0.79-12.2) 
 
 
 
0.11 
Sex with 
confirmed/suspected  
HIV 
No 
Yes 
 
 
1.0 
1.7 (0.58-5.08) 
 
 
 
0.33 
Social deprivation 
quantiles 
Not deprived (Q1-Q3) 
Deprived(Q4-Q5) 
 
 
1.0 
0.7 (0.26-1.8) 
 
 
 
0.44 
Material deprivation 
quantiles 
Not deprived(Q1-Q3) 
Deprived(Q4-Q5) 
 
 
1.0 
1.1 (0.39-3.05) 
 
 
 
0.86 
Total deprivation 
quantiles 
Not deprived (Q1-Q3) 
Deprived(Q4-Q5) 
 
 
1.0 
0.8(0.31-2.26) 
 
 
 
0.73 
          *OR- unadjusted odds ratio, CI Confidence interval 
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Table 3.6: Multivariable analysis : factors associated with the risk  for STI acquisition in 
the year before and after HIV diagnosis (Gender) (N=155)   
Variables *OR P- value 
Gender 
Male 
Female 
 
1.0 
6.1(0.98. - 37.7) 
 
 
0.05 
Men having sex with 
men 
No 
Yes 
 
 
1.0 
10.4(1.18 -91.9) 
 
 
 
0.04 
Sex Trade Work 
No 
Yes 
 
1.0 
4.7(0.9 -23.7) 
 
 
0.06 
Age 
<30 
30-39 
≥40 
 
1.0 
0.6(0.09 -3.7) 
0.9(0.1 -6.6) 
 
 
0.55 
0.9 
                     *OR - Adjusted odds ratios, CI Confidence interval 
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Table 3.7: Multivariable analysis : factors associated with the risk for STI acquisition in 
the year before and after HIV diagnosis (IDU) (N=155) 
 
Variables *OR P- value 
Injection drug use 
No 
Yes 
 
1.0 
0.7(0.1 -3.9) 
 
 
0.67 
M en having sex with 
men  
No 
Yes 
 
 
1.0 
3.3(0.5 -23.2) 
 
 
 
0.23 
Sex  Work 
No 
Yes 
 
1.0 
5.4(1.1 - 25.7) 
 
 
0.03 
Age 
<30 
30-39 
≥40 
 
1.0 
0.6(0.1 -3.8) 
0.6(0.1 -4.0) 
 
 
0.6 
0.6 
               *OR - Adjusted odds ratios, CI Confidence interval 
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Table 3.8: Multivariable analysis : factors associated with the risk  for STI acquisition in 
the year before and after HIV diagnosis (Gender and IDU)(N=155) 
Variables *OR(95%CI) P- value 
Gender 
Male 
Female 
 
1.0 
4.9(0.89 -27.3) 
 
 
0.067 
Injection drug use 
No 
Yes 
 
1.0 
0.2(0.03 -1.2) 
 
 
0.08 
Sex Trade Work 
No 
Yes 
 
1.0 
5.0(1.03 -24.6) 
 
 
0.05 
Age 
<30 
30-39 
≥40 
 
1.0 
0.5(0.08 -2.7) 
0.5(0.08 -2.5) 
 
 
0.42 
0.37 
                   *OR - Adjusted odds ratios, CI Confidence interval 
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3.5 Discussion 
The analysis of SHR health service data showed that gender is associated with the risk  for STI 
acquisition in the year before and after HIV diagnosis (OR 4.9), with marginal statistics 
significancy. This shows that  HIV-infected females have higher tendency for  STIs acquisition 
within one year before and after HIV diagnosis in SHR compared to their male counterpart.  
Our literature search did not find any study which examined risk factors for STI acquisition both 
before and after HIV diagnosis. There was also limited research that assessed risk factors that 
may affect STI acquisition before HIV diagnosis. However, a study by Kyriakos and colleagues 
indicated that a higher percentage of MSM and bisexual males had STI prior to HIV 
diagnosis,which was followed by IDU.(17) Note that the studies reported below in this paper 
focussed on the risk for STI acquisition after HIV diagnosis.  
The association between female gender and the risk of having other STIs among PLWH has been 
reported by several other studies.(18-21)  Romanoski et al. (2009), in their study conducted in 
Edmonton,Quebec, and Toronto, reported that females living with HIV have a higher risk of 
acquiring other STIs than HIV-infected males with OR 2.7. (21) This finding was supported by 
Belongia et al. in a study conducted  in United State (US).(18) Belongia et al. (1997) examined 
new STIs cases in a population based cohort of PLWH between 1993 and 1994.(18) Data for this 
study were provided by the Minnesota department of health, and they noted that STIs acquisition 
was related to the female gender with OR 3.8.(18)  
Conversely,  other studies reported that males living with HIV were more likely to be infected 
with other STIs than females.(5, 22-24) In a medical record-based study by Erbelding et al. , 
13.9% of 796 men and 11.9% of 354 women of PLWH were found to have acquired other 
STIs.(5) This observation was supported by Baffi et al. (22) Their analysis resulted in OR of 
2.88 in favour of women, indicating that men living with HIV are at greater risk of acquiring 
STIs.(22) The discrepancy in these observations could have been due to the higher number of 
male participants in this study, as 76% of their participants were men. (22) It was also noted that 
majority of the men in this study were MSM, which is a high-risk group for STIs. (22) In 
addition, Baffi and colleagues examined only syphilis  in PLWH, and most of the clients with 
this co-infection happened to be male(22). Manning et al.(2007) reported that about 80% of 
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PLWH who acquired STIs were male, and the majority of these men were also MSM. (24) On 
the other hand, Kalichman et al. (2011), in a systematic review, observed an identical prevalence 
of other STI  in both HIV-infected women (15.8%) and men (13.6%), implying that both genders 
have almost the same likelihood of acquiring STIs.(25) 
The association between female gender and STI acquisition might be due to a number of factors, 
one of which could be as a result of females reporting more STIs symptoms than males.(26) 
More women are generally observed to access medical care and services compared to men, and 
this could lead to more screening for STIs.(18) In addition, considering the efficient transmission 
of HIV from males to females (27), sexual violence against women could also contribute to their 
being infected with STIs.(28)  Another potential reason for the acquisition of STIs among these 
women is the dependence on their husbands and sex partners for financial support. (29-32) This 
limits their say with regards to safe sex, and increases their odds of acquiring STIs. 
Biomedically, the wide vagina mucosa surface of  women might also increase their tendency of 
STI acquisition. (21) 
In our study, sex work was associated with the risk  for STI acquisition in the year before and 
after HIV diagnosis with OR 5.0. The association between sex work and the acquisition of other 
STIs was supported by several other studies.(33-36) Hague and colleagues (2011) identified sex 
work  to be significantly associated with STIs acquisition in PLWH with OR of 2.77.(35) This 
study noted that continous engagement in high-risk sexual behavior, even after being diagnosed 
with HIV, was one of the reasons this subgroup was at risk of acquiring STIs.(35) This 
conclusion was seconded by  Diaz et al.(34) Diaz et al.(2009), in a study conducted in Spain, 
observed that the OR of having syphilis and gonorrhea in sex workers living with HIV was 4.8 
and 18.4 respectively, even though these measures of estimates were not significant.(34) Sex 
workers are then identified  as an important population for the acquisition and transmission of 
other STIs and HIV.(37, 38) 
Surprisingly, our analysis showed no association between IDU and the risk for STI acquisition in 
the year before and after HIV diagnosis in SHR (OR 0.2), having adjusted for potential 
counfounders. Similar results have been observed in some other studies. (20, 23, 24) Manning et 
al. (2007) reported that IDU living with HIV are less likely to acquire STI when the STIs were 
analysed separately with OR 0.7, 0.8,0.5 for gonorrhea, syphilis, and chlamydia respectively. 
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(24) Baffi et al.(2010), in their study which explored illicit drug use as a variable and not IDU 
alone, did not notice an association between illicit drug use and acquisition of STI in persons 
with HIV with OR  1.14. (22) 
This is not to say that the use of intravenous drugs is not associated with a tendency of high-risk 
sexual behavior. The use of these drugs alters mental capacity for making reasonable decisions 
regarding safe sex practises (10), thus increasing the possibility of STI acquisition in PLWH.(9) 
The presence of STIs in PLWH is a proxy marker that this group of individuals continously 
engage in high-risk behavior,even after been diagnosed with HIV, causing transmission of other 
STIs and further HIV transmission and progression.(18) 
Results from our analysis helped to pinpoint subgroups amongst PLWH that may be at high-risk 
of having STIs. These subgroups should be given high considerations in terms of program 
planning and interventions.  Other subgroups should not be left out of intervention programs, 
because excluding these groups of PLWH will only result in an increase in STIs transmission 
amongst this population. The findings in our study might be different from that of other studies 
due to variation in study design, sample size and population characteristics. 
Globally, HIV prevention programs do not consider routine screening for STIs in this population, 
which makes asymptomatic STIs undiagnosed and underreported.(24) In this case, health care 
providers should maximise every contact they have with PLWH by inquiring about high-risk 
behaviors such as high-risk sexual activity and subtance abuse. (24)  Individuals at risk of other 
STIs should also be screened during these contacts so that infections can be detected and treated 
on time because in most instances STIs may be asymptomatic, especially in women. (24, 35) The 
role of counselling should also be underscored in the reduction and prevention of STI acquisition 
in HIV. Some studies have observed a decrease in high-risk behaviors among individuals that 
tested for HIV after being counselled.(35) Therefore, PLWH should be engaged in regular 
counselling sessions during their visits to the health facilities. (24, 35) In our case, the message 
should center around the practise of safe sex (regular use of condoms) and safe use of 
intravenous drugs.  
Prevention and reduction of STI acquisition amongst hard to reach population such as sex worker 
may be possible through community-based STI screening and treatment program. Several studies 
reported a high rate of STI screening and treatment with community based facilities.(40-42) A 
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study conducted by Poulin et al. among women with social problems, sex workers, and street 
youth, in Quebec City recorded that all their participants conceded to STI screening in their 
community based program.(40) Out of those with STI infection, 93% were treated.(40) Identical 
treatment rate had been documented earlier in other United State community based screening 
programs.(41, 42) Success in these programs may be due to several factors. This includes service 
delivery by “familiar and trusted community workers with a non-judgmental approach”, non-
invasive mode of STI screening, and treatment by personal physician or community based 
clinic.(40;p.442, 43) Individuals not willing to use the conventional medical facilities had the 
choice of getting their treatment from community organization offices.(41) These services should 
not be available to sex workers alone, but their clients should also be partakers of such services 
in order to have lesser infections and complications.(44) 
Two studies reviewed the effectiveness of HIV preventive programs for women at risk of HIV 
infection, one was conducted in Canada, United State, and Puerto Rico (45), and the other in 
United State.(46) They both reported that the most effective women HIV preventive programs 
had certain characteristics, which includes women only programs, gender based (power 
imbalance and sexual assertiveness), peer led, and requires several sessions.(45,46)These 
program characteristics also apply to HIV/STI preventive programs addressing sex worker.(44) 
STI preventive programs targeting women and sex worker should also consider addressing 
sexual violence in these population.(37, 43) 
HIV/STI preventive programs should not only be individualistic-centered, but structural factors 
contributing to acquisition of these infections should also be given attention.(31,44) With the 
realization that an important factor that might contribute to STI acquisition in women is their 
financial dependence on their husbands and male partners(29-32), HIV/STI prevention strategies 
should include economic empowerment programs and policies.(31) More information on SES is 
available in Section 2.2.3. of this thesis. Programs addressing low SES in women may include 
microfinancing/micro credit program.(31, 47,48)This program provides loans to individuals with 
low income, who do not have steady employment, credit history, and collateral, thus helping 
with poverty alleviation, particularly in women.(31,47,48) Putting such program in place will 
empower these women, enabling them to have a say regarding safe sex practises, thus reducing 
their risk of STI acquisition. 
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Community empowerment programs underscoring self esteem and empowerment could also be 
targeted at women and sex workers.(46)  These programs can help with skills development, 
enabling women to protect themselves from unsafe sex, and also strengthen their practice of safe 
sex.(44,46) Women enrolled in such program work together to tackle barriers to safer sex.(44) 
Drug use has been observed to be common among sex workers (sex work harm), and also among 
women with male IDU sexual partners (30,49), thus harm reduction programs such as NEP could 
be incorporated into programs targeted at these subgroups.  
Not one intervention programs can provide maximum HIV/STI prevention to these subgroups, 
however, combination of interventions at various levels (individual and structural) will provide 
ultimate reduction in the prevalence of these STIs.(44) 
Strengths and limitations  
We acknowledge that health services data has limitations. Notwithstanding, it is better to have an 
insight to this problem using these data rather than not having any idea about the risk factors 
implicated in the acquisition of other STIs amongst PLWH in SHR. 
As far as we know, this is the first study identifying risk factors for STIs acquisition among 
PLWH in SHR and Saskatchewan. It also adds to the body of knowledge regarding this 
association in Canada. Our study identified factors that could contribute to the acquisition of 
STIs within a year before and after HIV diagnosis in SHR. These factors would guide the choice 
of intervention programs. It further prevents the transmission of HIV, since SHR has the highest 
number of HIV cases in the province since 2005.(50,51) 
The study had its own limitations. Gathering data on sensitive topics such as sexual orientation, 
engagement in sex work, and IDU could be challenging. Thus, the limited number of participants 
available for the analysis is a major limitation in this study. The marginal statistical association  
of gender, large confidence interval, non significant association for other covariates,   and our 
inability to test interaction may be explained by inadequate statistical power due to our small 
sample size.  
Also, we did not have the opportunity to compare differences in characteristic between 
participants whose data were included in the study and those not. Forty nine PLWH who 
acquired other STIs outside 365 days before and after HIV diagnosis were excluded from our 
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analysis. Also, ninety-two participants were excluded from the data set because of missing data 
on history of STIs. We acknowledge that the two groups may be significantly different and we 
have asked that caution be taken when interpreting the results of our study due to this limitation.   
Even though our selection criteria identified a group without STIs, which was compared with 
those with STIs, we cannot overlook the fact that some participants in this group might not have 
been tested for STIs within 365 days of HIV diagnosis, resulting in their misclassification. 
Misclassification of this participants may distort the observed association between the 
independent variables (gender or IDU) and the risk for STI acquisition in the year before and 
after HIV diagnosis. Records of HIV and other reportable STIs do not follow individuals when 
they move from one health region to another, thus the accuracy of selecting a group without STIs 
may be compromised. 
The primary sources of HIV exposure (risk factors) used for this analysis are not mutually 
exclusive, therefore there is a potential for misclassification. It remains to be determined if the 
association will be similar if the sources of HIV exposure were to be mutually exclusive. 
The SHR data set had some data missing, these missing data could introduce some bias by  
affectingour effect estimate if the characteristics of the missing data differ from the 
characteristics of the used data 
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3.6 Conclusion 
Recognition of risk factors contributing to acquisition of other STIs in PLWH is very crucial. 
Identifying these factors guides development of  preventive programs that could reduce or 
prevent acquisition of other STIs among PLWH, and also prevent further HIV transmission. The 
knowledge of local epidemics with regard to HIV and other STIs transmission is very essential in 
the fight against HIV and STIs transmission.(47) 
Findings from this study reveal that after adjusting for other independent variables,    females are 
significant predictor of the risk for STI acquisition in the year before and after HIV diagnosis in 
SHR. Sex workers are also significant predictor of the risk for STI acquisition in the year before 
and after HIV diagnosis in SHR.  However, IDU was not  associated with this risk. Future 
studies with larger sample size, preferably a prospective cohort is needed to further explore these 
associations since there were no studies exploring the risk  for STI acquisition before and after 
HIV diagnosis. This research will better inform evidence based public health practice targetted at 
reducing other STIs and HIV infection. The observed  association between being a female and 
the risk of STI acquisition among PLWH shows it is important to understand factors that 
influence the acquisition of these STIs in women. A larger study looking specifically at women, 
and exploring factors that influence the acquisition of these STIs, is essential. 
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Chapter 4: Manuscript 2: Is gender OR injection drug use a risk factor for acquiring 
sexually transmitted infections among people living with HIV in developed countries? A 
systematic review and meta-analysis. 
4.1 Abstract  
Background: The global impact of sexually transmitted infections (STIs) on health morbidity 
and mortality cannot be overemphasized, with about 40 million people PLWH and over 340 
million newly diagnosed STIs (other than HIV) per year. The prevalence of STIs have been 
reported as high amongst PLWH.  
Objectives: To determine if gender is a risk factor for acquiring other STIs in PLWH in 
developed countries. To determine if IDU is a risk factor for acquiring other STIs in PLWH in 
developed countries.  
Methods: A systematic review and meta-analysis was conducted according to MOOSE and 
EPHPP recommendations. Its reporting was guided by Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guideline.Studies from developed countries addressing 
acquisition of other STIs in PLWH were identified for use in our study. Relevant data were 
abstracted and differences in OR across the studies and heterogeneity were examined using 
meta-analysis. 
Result: Ten articles were reviewed for  gender analysis, and these studies were conducted in  
four countries. The pooled OR for HIV-infected females acquiring other STIs compare to males 
was 1.38 (CI: 0.75 – 2.55; p-value= 0.30) with a high heterogeneity of I2 = 96%. For  IDU 
analysis, six articles were reviewed from two countries.  The pooled OR for IDUs acquiring 
other STIs compare to non-IDUs was 0.71 (CI: 0.4 -1.29; p-value=0.26) with a high 
heterogeneity of I2 = 85%.  
Conclusion: The diagnoses of other STIs in PLWH suggest continous exposure of non-infected 
individuals to both HIV and other STIs. Hence, public health practitioners globally should 
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prioritize intervention programs addressing behavioral activities that could lead to acquiring 
other STIs in PLWH. 
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4.2 Introduction 
The global impact of sexually transmitted infections (STIs) on health morbidity and mortality 
cannot be overemphasized, with over 340 million newly diagnosed STIs (other than HIV) in 
1999. (1) The prevalence of STIs have been reported  high amongst PLWH. (2) Identifying other 
STIs in HIV-infected people suggest that these individuals continue to engage in high risk sexual 
behavior, exposing non-infected persons to HIV.(3, 4) The presence of these STIs expedite HIV 
progression and also its transmission.(3) 
 Considering the high prevalence of STIs in PLWH, it is important to identify the population at 
risk in order to reduce the risk of transmission of these STIs and also that of HIV.(5) This study 
earlier explored the independent relationship between gender and the risk for STI acquisition in 
the year before and after HIV diagnosis in  Saskatoon Health Region. It also explored the 
relationship between IDU and the risk for STI acquisition in the year before and after HIV 
diagnosis, in  SHR. However, because of the limitation of SHR health service data on the 
dependent variable (STIs in PLWH), and its limitation on potential risk factors, a systematic 
review and meta-analysis of studies exploring risk factors for the acquisition of other STIs in 
PLWH in developed countries was conducted. Note that the risk for acquiring other STIs in HIV 
in this study considered STI acquisition after HIV diagnosis.  
The analysis explored developed countries because studies on risk factors for acquiring STIs in 
PLWH was also limited in Canada. We also took into consideration their comparable context to 
Canada.The review aims to determine if gender is a risk factor for acquiring STIs among PLWH 
in developed countries and to determine if IDU is a risk factor for acquiring STIs among PLWH 
in developed countries.  
4.3 Methods 
This systematic review and meta-analysis was conducted according to MOOSE  (6), and EPHPP 
(7) recommendations. Its reporting was guided by Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guideline, 2009 revision (8). 
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Research Protocol  
The research protocol provides a description of the methods that were applied to carry out the 
review. For this study, the protocol involves identifying inclusion and exclusion criteria, search 
terms, study quality descriptors, and data synthesis procedures. 
 
4.3.1 Criteria for considering studies for meta-analysis (Inclusion and exclusion criteria) 
Types of studies 
Observational studies were included in this review and analysis. These include cohort, case-
control, longitudinal, and cross-sectional studies. 
Country/Location for the study 
The review included studies conducted in developed countries.  Developed countries 
classification for this study was based on the United Nations classification of countries.(9)  
Types of participants and recruitment center 
Studies considered for this review had their population sample made up of individuals with HIV 
or drug users with HIV. Both male and female samples were included for the gender analysis. 
HIV- infected male and female who acquired other STIs were also included . Injection drug user 
and non-IDU were used for the IDU analysis. 
Recruitment sites for the studies were grouped into three broad categories: illicit drug treatment 
center, infectious/HIV/STI clinic, and hospital outpatient clinics. Studies included in this review 
were from any of the three mentioned centers. 
Measurement of study outcome  
The outcome of the review is the risk of acquiring other STIs amongst PLWH. For a study to be 
eligible for review and analysis, HIV and other STIs in the study were reported to have been 
previously diagnosed by the physician or laboratory diagnosed. This was to avoid information 
bias that can be created by self-reporting. 
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Language 
Only articles written in English language were considered for the analysis. 
Study years included 
The search included publications from January 1985, when HIV antibody testing became 
generally available to December 2016. Thus, studies before 1985 even when relevant were 
excluded. 
4.3.2 Data sources and search strategy 
In order to identify eligible papers for this study a comprehensive literature search was 
conducted using scientific database such as Medline, PubMed, Embase, Proquest Public Health, 
Web of science and Global Health. The reference list of the 6 most recent articles, relevant, and 
review articles were also manually searched. A search strategy was developed on MEDLINE 
(see appendix D), and this was translated  to the remaining databases. This search strategy was 
developed for four concepts: Human immunodeficiency virus, risk factor (gender OR IDU), 
sexually transmitted infections, and country.The data search was done in close collaboration with 
a librarian, and it took place between October 2015 and December 10th 2016. Search terms used 
for MEDLINE are detailed below 
Table 4.1: Search term 
Concept #1 Concept #2 (Risk factors) Concept #3 Concept #4 
Human 
immunodeficienc
y virus 
Injection drug use Gender Sexually 
transmitted 
infections 
Country 
HIV / human 
immunodeficienc
y syndrome/ 
human immun*/ 
HIV infection/ 
HIV infect*/ HIV 
prevalence 
/AIDS/acquire 
Injecting drug 
abuse/ intravenous 
drug 
abuse/injecting 
drug 
user/Injection 
drug 
use/IDU/substanc
Female 
and male 
Sexually 
transmitted 
diseases/STD/ 
sexually 
transmitted 
infections/STI/sy
philis/ treponema 
pallidum/chancre/ 
Developed 
countries/develope
d nation OR use of 
names of the 
different qualified 
countries 
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immunodeficienc
y syndrome 
/acquire immun*  
 
e abuse 
injection/inject* 
drug 
abuse/substance 
abuse 
inject*/heroin 
/heroin 
dependence/drug 
addiction 
 
chancroid / 
Haemophilus 
ducreyi / neisseria 
gonorrhoeae/ 
gonorrhea / 
chlamydia 
trachomatis/ 
chlamydia 
infections /herpes 
genitalis /herpes 
simplex 
/herpesvirus 2/ 
lymphogranuloma 
venereum / 
trichomonas 
vaginitis 
 
 
4.3.3 Data collection and analysis 
4.3.3.1 Study Selection  
One investigator (GA) scanned titles of all generated articles  to identify relevant papers in line 
with the study topic. Articles not written in English language and duplicate papers from different 
data bases were excluded. The articles were read in full, to be sure it contains all the inclusion 
criteria for the study.  
4.3.3.2 Quality assessment 
The quality of eligible studies were assessed using the EPHPP quality assessment tool for 
quantitative studies and its dictionary (see appendix E & F).(7) This tool has been assessed to be 
reliable, with adequate content and construct validity.(10) It was also awarded a strong 
methodological rating by the National Collaborating Centre for Methods and Tools.(11) 
Extraction of the data was by GA, and it was verified by MS. 
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Two raters reviewed  the study quality using the global rating scale (GA,MS)2. Six components 
were considered in the global rating and these includes selection bias, study design, confounding, 
blinding, data collection method, and withdrawal/ dropouts rates.(7) The global rating scale 
indicates the study is “strong” when none of its component has a weak rating, “moderate” when 
only one component has a weak rating and “weak” when two or more of its component has a 
weak rating.(7) The two reviewers then discussed the discrepancies from the extracted data and 
came to a unanimous decision.  
4.3.3.3 Data abstraction 
Details of number of obtained references, number of retrieved full text papers, and number of 
included and excluded articles were documented. This data was managed in Endnote. Relevant 
data were abstracted from eligible articles and entered into a standard Excel template. The data 
covered information such as study authors, publication year, males and females living with HIV, 
number of PLWH using intravenous drugs , those not using intravenous drugs and those with 
HIV and other STIs, study design, and statistical indicator (OR). Two investigators  reviewed  
the abstracted data (GA,JL)3. Extraction of the data was by GA, and it was verified by JL. 
Discrepancies were resolved through discussion. Relevant data were entered into the Review 
Manager (RevMan)  software. 
     4.3.3.4 Statistical analyses (Meta-analysis) 
The ORs for acquiring other STIs amongst HIV- infected females to males  were calculated from 
abstracted females and males HIV/STI prevalence. The ORs for IDU and non-IDU were also 
calculated and meta-analysis was carried out on them.  Forest plot was used to illustrate these 
ORs, with their 95% confidence intervals at p-value <0.05. While funnel plots was used to assess 
for publication bias. Egger’s test was also used to assess for publication bias because unlike the 
funnel plot  it affords the study a better objective means of evaluating the reliability of the result. 
Random effects was used for weighting of the ORs and heterogeneity in effects was assessed by 
visualising the graphical plot and  using the I2 statistic. Review Manager 5.3 was used for the 
analysis, but stats direct was used to calculate Egger’s test. 
                                                          
2 GA- Grace Akinjobi, MS -Michael Schwandt 
3 GA- Grace Akinjobi, JL-June Lim 
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4.4 Results 
Search results  
Figure 4.1 and 4.2 shows the PRISMA outlines for the first (gender) and second  (IDU) research 
questions, respectively.The two outlines illustrate the process of study selection.  
For “gender” search 19,578 titles were identified, out of which 2,321 non-English and 2,963 
duplicates were excluded. One hundred and fifteen abstracts were retained  after evaluation, and 
41 of these  articles were retrieved for detailed evaluation. Ten articles met the study inclusion 
criteria. Most articles were excluded because they were irrelevant, full text was not available, did 
not report acquisition of STIs in PLWH  by gender, and did not have clear HIV and other STIs 
diagnostic criteria. Studies were also excluded due to incomplete data, lack of clarity on time of 
STI acquisition, studies from the same research project, and analysis based on the same 
population sample.  
The “IDU” search produced 6,776 titles, out of which 812 were non-English and 719 duplicates 
were excluded. One hundred and fifty abstracts were retained  after evaluation, and 44 of these  
articles were retrieved for detailed evaluation. Six articles met the study inclusion criteria. 
Articles were excluded from this analysis based on similar reasons above and not reporting 
acquisition of STIs in PLWH by IDU. 
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• No full text 
available 
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alone 
In
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41 full text articles 
reviewed 
 
10 studies included 
in systematic review 
and meta-analysis 
 
• Studies from the 
same research 
project 
• Studies not reporting 
acquiring STI in 
PLWH by gender 
• No clear HIV & STI 
diagnostic criteria/ 
investigation 
Figure 4.1: PRISMA flow diagram: gender as a risk factor for acquiring other sexually 
transmitted infections in people living with HIV in developed countries 
 
 
 
92 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6,776 records identified 
through database searches 
   
S
cr
ee
n
in
g
 
Id
en
ti
fi
ca
ti
o
n
 
5,964 records after nonEnglish 
was removed 
5,245 records 
screened 
 
150 potentially 
relevant study 
abstracts retrieved 
E
li
g
ib
il
it
y
 
719 duplicates 
excluded 
 
• Irrelevant 
• No full text 
available 
 
In
cl
u
d
ed
 
44 full text articles 
reviewed 
 
6 studies included 
in systematic 
review and meta-
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Figure 4.2: PRISMA flow diagram: injection drug use as a risk factor for acquiring other 
sexually transmitted infections in people living with HIV in developed countries 
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Is gender a risk factor for acquiring other STIs in PLWH in developed countries? 
Study characteristics and quality  
Table 4.2 below summarizes study characteristics from the 10 included studies. Seven of the 
studies were conducted in the United States  (3, 4, 12-16), and a study each from Canada, Italy, 
and Netherland.(17-19) Three study designs were identified by the review. Out of the 10 studies, 
4 were retrospective cohort studies (4, 12, 13, 15), 3 prospective cohort (3, 17, 18), and 3 cross 
sectional  studies.(14, 16, 19) The settings for recruitment of participants for the studies vary per 
study. Majority of the studies, recruited study participants from HIV/STIs/infectious disease 
clinics.(3, 4, 12, 13, 16-19) The participants in 9 studies were PLWH (3, 4, 12, 13, 15-19), while 
that for the remaining one were illicit drug users with HIV.(14) Do (2001) followed up their 
cohort for 7 years (15), while Kalichman (2000) only followed theirs for 9 months.(3) Studies in 
this review captured STIs either by laboratory diagnosis or using a set definition.(3, 4, 12-19) In 
five studies STIs were measured using laboratory diagnosis only (12, 14, 15, 17, 18), four used 
sets of definition (3, 4, 16, 19), and only one captured STIs using laboratory diagnosis together 
with a definition.(13) Sexually transmitted infections studied in the included papers varied by 
studies, with 2 studies exploring HSV (14, 19), 2 on syphilis (12, 17), 1 on gonorrhea (15), and 
the remaining five had multiple STIs explored.(3, 4, 13, 16, 18) 
Table 4.3 below summarizes quality of the included studies. The findings from the quality 
assessment showed that 6 out of 10 studies had a weak methodological rating (3, 13, 14, 16, 18, 
19), 3 had a moderate rating (4, 12, 17), and the last a strong rating.(15) Since the inclusion and 
exclusion criteria for this review exclude quality assessment findings of the studies, all ten 
studies were included in the review.  
9
4
 
 
 
 
  
Table 4.2: Summary of characteristics of included studies (Gender) 
Study name Country Study 
design 
Population Type of 
STIs 
STI def. STI 
diag. 
Exposure Follow up Recruitment site 
Baffi (2010) USA RC PLWH Syp  RPR MSM, 
HET,IDU 
Not Available HIV clinic 
Belongia 
(1996) 
USA RC PLWH Syp,GC, 
CH 
diagnosed 
STI 
Culture,
FTA 
MSM, 
IDU,HET 
Not Available HIV clinic, 
hospitals 
Cicconi 
(2008) 
Italy PC PLWH Syp  TPHA MSM, 
IDU,HET 
 
Not Available 
Infectious disease 
clinics 
Des Jarlais 
(2014) 
USA CS Drug users 
with HIV 
HSV  ELISA MSM, 
IDU,HET 
NA Illicit drug 
treatment center 
Do 
(2001) 
USA RC PLWH GC  culture 
or gram-
stain 
MSM, 
IDU,HET 
7years Hospitals, 
outpatient clinics, 
emergency room 
Heiligenberg 
(2012) 
Netherland PC PLWH GC,CH, 
Syp 
 Nucleic 
acid 
amplicat
ion test, 
RPR 
HET Not Available HIV clinic 
Kalichman 
(2011) 
USA CS PLWH GC,CH, 
Tri,Syp, 
HSV 
diagnosed 
STI 
 HET,IDU NA HIV clinic 
Infectious disease 
clinic 
Snowball 
9
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technique 
Kalichman 
(2000) 
USA PC PLWH GC,CH, 
NGU, 
Tri, Syp, 
HSV 
diagnosis 
of an STI 
in the last 
3months 
  9months Infectious disease 
clinics 
Manning 
(2007) 
USA RC PLWH GC,CH, 
Syp 
STI 
diagnosed 
after HIV 
diagnosis 
 MSM, 
IDU,HET 
Not Available HIV clinic 
Infectious disease 
clinic 
Hospitals 
Romanowski 
(2009) 
Canada CS PLWH HSV history of 
herpes 
 MSM, 
HET, 
IDU, 
persons 
from 
endemic 
country, 
persons 
that have 
sex with 
someone  
NA Infectious disease 
clinic 
9
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Legend  
CS- Cross sectional                    GC- Gonorrhea            NGU- Non gonococcal urethritis                                     
PC- Prospective cohort             CH-  Chlamydia            FTA-   Fluorescent treponemal antibody 
L-   Longitudinal                        Syp-  Syphilis                 RPR - Rapid plasma reagin                          
RC- Retrospective cohort         Tri- Trichomonas                  HOM- Homosexual                    
HSV-Herpes simplex virus         HPV- Human papilloma virus              
HET- Heterosexual                   NA- Not applicable 
TPHA- Treponema pallidium Hemagglutination assay 
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Table 4.3: Summary of quality of the included studies (Gender) 
 
Study name Selection 
Bias 
 
Study 
Design 
Confounders Blinding 
 
Data Collection 
Methods 
Withdrawals and 
Drop-outs 
Conclusion 
Baffi (2010) Moderate Moderate Moderate Not 
Applicable 
Moderate Weak Moderate 
Belongia 
(1996) 
Moderate Moderate Weak Not 
Applicable 
Moderate Weak Weak 
Cicconi 
(2008) 
Moderate Moderate Strong Not 
Applicable 
Moderate Weak Moderate 
Des Jarlais 
(2014) 
Moderate Weak Weak Not 
Applicable 
Moderate Moderate Weak 
Do  
(2001) 
Moderate Moderate Strong Not 
Applicable 
Moderate Moderate Strong 
Heiligenberg 
(2012) 
Moderate Moderate Weak Not 
Applicable 
Moderate Weak Weak 
Kalichman  
(2011) 
Weak Weak Moderate Not 
Applicable 
Weak Moderate Weak 
Kalichman 
(2000) 
Weak Moderate Weak Not 
Applicable 
Moderate Moderate Weak 
9
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Manning 
(2007) 
Moderate Moderate Moderate Not 
Applicable 
Moderate Weak Moderate 
Romanowski 
(2009) 
Weak Weak Weak Not 
Applicable 
Moderate Moderate Weak 
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Data extraction 
Table 4.4 below summarizes data from the included studies. The 10 papers consist of 61,302 
participants, 14, 559 females and 46,743 males.(3, 4, 12-19) Manning study had 1% of data for 
PLWH and 0.1% for HIV/STI  missing, but it was still included in our analysis because we 
believe the available data could contribute to the explored association with only ≤1% missing 
data. 
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Table 4.4: Summary of extracted data from included studies (Gender) 
 
Study name Country HIV/STI 
          
HIV alone OR (95%CI)1 p-
value 
  Females Males Females Males   
Baffi (2010) USA 4 36 369 1175 0.4(0.12-0.98) 0.05 
Belongia (1996) USA 9 21 242 2073 
 
3.8(1.71-8.34) <0.001 
Cicconi (2008) Italy 10 75 529 
 
1215 
 
0.3(0.15-0.57) <0.001 
Des Jarlais (2014) USA 108 170 114 250 8.5 (3.57-20.1) <0.001 
Do (2001) USA 221 460 6859 29243 2.1 (1.77- 
2.45) 
<0.001 
Heiligenberg 
(2012) 
Netherland 3 1 141 104 2.2(0.23-21.8) 0.49 
Kalichman (2011) USA 81 209 155 415 1.08(0.75-
1.56) 
0.69 
Kalichman (2000) USA 18 24 112 228 1.63(0.84-
3.14) 
0.15 
Manning 
(2007) 
USA 146 
 
577 
 
5864 
 
11585 
 
0.5(0.41-0.59) <0.001 
Romanowski 
(2009) 
Canada 124 219  174 455 2.7(1.83-3.89) <0.001 
1 This is the odds of a female co-infected with HIV and other STIs compared to male 
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Odds of HIV- infected female acquiring other STIs compared to male  
These studies were ordered in forest plot and their effect estimates examined (see Figure 4.3). 
The OR for these studies (3, 4, 12-19), varies from 0.35 to 8.47, and 7 of these ORs (4, 12-15, 17, 
19) were statistically significant .The pooled OR for females   compared to males for acquiring  
STI’s amongst PLWH was 1.38 with 95% CI ranging from 0.75 to 2.55 and p- value of 0.30 (see 
Figure 4.3). 
 
 
 
Figure 4.3: Forest plot of odds of HIV- infected female acquiring other sexually transmitted 
infections compared to male in developed countries 
Heterogeneity  
Figure 4.3 shows forest plot illustrating the heterogeneity amongst ORs female: male for 
acquiring  STI’s amongst PLWH  in developed countries . The effect estimates in this plot were 
on both sides of the reference line, with their confidence intervals poorly overlapping, suggesting 
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a high heterogeneity in the studies. This was supported by I² at 96%, p-value <0.001. Note:  I2 > 
40% is regarded as high heterogeneity for this study.(20) 
Potential publication bias 
Figure 4.4 depicts the funnel plot for the risk of  acquiring  STIs in a HIV- infected females 
compared to males in developed countries. The graph shows effect size (OR) on the x-axis and 
standard error of the log OR on the y-axis.  The observed  plot was asymmetrical and Egger’s test 
p-value was 0.78.  
Figure 4.4: Funnel plot of odds of HIV- infected females acquiring other sexually 
transmitted infections compared to males in developed countries 
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Is Injection drug use a risk factor for acquiring other STIs in PLWH in developed countries? 
Table 4.5 below summarizes study characteristics from the 6 included studies. Five of these 
studies were conducted in the United States (4, 15, 16, 21, 22), while the remaining one was from 
Italy.(17) Three study designs were identified by the review.  Out of the 6 studies, 3 were 
retrospective cohort studies (4, 15, 21), 2 prospective cohort(17, 22), and  the remaining one a 
cross sectional study.(16) The settings for recruitment of participants for the studies vary per 
studies. Five studies recruited study participants from HIV/STIs clinics (4, 16, 17, 21, 22), and 
the last one from hospitals outpatient.(15) The participants in all 6 studies were PLWH (4, 15-17, 
21, 22), and their follow up period ranges from 6 months to 7 years (15, 21, 22). Studies in this 
review captured STIs either from laboratory diagnosis or using a set definition (4, 15-17, 21, 22). 
In 2 studies (4, 16, ), STIs was measured using sets of definition only, 2 used laboratory 
diagnosis(15, 17) , and the last 2 captured STI using laboratory diagnosis together with a 
definition (21, 22). Sexually transmitted infections studied in the included papers varied by 
studies, with 4 studies exploring multiple STIs (4, 16, 21, 22), 1 on syphilis (17), and 1 on 
gonorrhoea.(15)
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Table 4.5: Summary of characteristics of included studies (IDU) 
Study name Country Study 
design 
Population Type 
of 
STIs 
STI 
def. 
STI diag. Exposure Definition of 
IDU 
Follow 
up 
Recruitment 
site 
Cicconi 
(2008) 
Italy PC PLWH Syp  TPHA MSM, 
IDU, 
HET 
 
 
Not 
Avai-
lable 
Infectious 
disease clinics 
Do 
(2001) 
USA RC PLWH GC  culture or 
gram-stain 
MSM, 
IDU, 
HET 
IDU in the 
6mths prior/ at 
time of 
gonorrhea 
diagnosis and 
ART 
prescription 
7yrs Hospitals, 
outpatient 
clinics, 
emergency 
room 
Hague 
(2011) 
USA RC PLWH GC, 
CH, 
Syp 
STI in 
30 
days 
or 
more 
after 
Nucleic Acid 
Amplif-ication 
tests, RPR 
MSM, 
IDU, 
HET, 
CSW 
IDU during 
the 12 months 
before  HIV or 
STI diagnosis 
4yrs STD clinic, 
private 
providers 
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HIV 
diag-
nosis 
Kalichman 
(2011) 
USA CS PLWH GC, 
CH, 
Tri, 
Syp, 
HSV 
diag-
nosed 
STI 
 HET, 
IDU 
 NA HIV clinic 
Infectious 
disease clinic 
Snowball 
technique 
Manning 
(2007) 
USA RC PLWH GC, 
CH, 
Syp 
STI 
diag-
nosed 
after 
HIV 
diagno
sis 
 MSM, 
IDU, 
HET 
 Not 
Avai-
lable 
HIV clinic 
Infectious 
disease clinic 
Hospitals  
Mayer 
(2012) 
USA PC PLWH GC, 
CH, 
Syp 
New 
STI 
diag-
nosed 
at 
6mths 
Nucleic Acid 
Amplif-ication 
tests, 
VDRL,RPR, 
FTA 
HET, 
IDU, HOM, 
Injecting drugs 
at 6months 
6mths HIV clinic 
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Legend  
CS-  Cross sectional      GC- Gonorrhea               NGU-Non gonococcal urethritis     
PC-  Prospective cohort    CH- Chlamydia                   HSV-Herpes simplex virus                   
L-  Longitudinal             Tri-Trichomonas              FTA- Fluorescent treponemal antibody 
RC- Retrospective cohort  Syp- Syphilis                 RPR- Rapid plasma reagin  
HOM- Homosexual                   HPV- Human papilloma virus 
HET-  Heterosexual               NA-Not applicable  
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Table 4.6: Summary of quality of the included studies (IDU) 
 
Study 
name 
Selection 
bias 
 
Study design Confounders Blinding 
 
Data collection 
methods 
Withdrawals 
and drop-outs 
Conclusion 
Cicconi 
(2008) 
Moderate Moderate Strong Not 
Applicable 
Moderate Weak Moderate 
Do (2001) Moderate Moderate Strong Not 
Applicable 
Moderate Moderate Strong 
Hague 
(2011) 
Moderate Moderate Moderate Not 
Applicable 
Moderate Moderate Strong 
Kalichman  
(2011) 
Weak Weak Moderate Not 
Applicable 
Weak Moderate  Weak 
Manning 
(2007) 
Moderate Moderate Moderate Not 
Applicable 
Moderate Weak Moderate 
Mayer 
(2012) 
Moderate Moderate Weak Not 
Applicable 
Moderate Strong Moderate 
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Table 4.6 above summarizes quality of the included studies. The methodological rating of the 
studies are as follows: 3 moderate (4, 17, 22), 2 strong (15, 21) , and the last was a weak 
rating.(16) Since the inclusion and exclusion criteria for this review do not include quality 
assessment findings of the studies, all 6 studies were included in the review.  
Data extraction 
Table 4.7 below summarizes data from the included studies. The 6 papers included of 56,846 
participants, 8,953 IDUs and 47,893 non-IDUs (4, 15-17, 21, 22).  
These studies were ordered in forest plot and their effect estimates examined (see Figure 4.5 
below). The OR’s from the studies in this review ranged from 0.33 to 2.48, at p-value <0.05 (4, 
15-17, 21, 22). The pooled OR for IDUs compared to non-IDUs for acquiring  STI’s amongst 
PLWH was 0.71 (95% CI: 0.4 -1.29; p-value-0.26) (see Figure 4.5 ).  
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Table 4.7: Summary of extracted data from included studies (Injection Drug Use) 
 
2This is the odds of an IDU PLWH co-infected with other STIs compared to non-IDU PLWH 
 
Study name Country HIV/STI HIV alone OR (95%CI)2 P value 
  IDU NON IDU IDU NON IDU   
Cicconi (2008) Italy 17 68 734 1010 0.33(0.19-0.56) <0.001 
Do (2001) USA 77 604 5415 30687 0.7 (0.57-0.91) 0.01 
Hague (2011) USA 8 45 36 388 2.2 (0.94-5.07) 0.07 
Kalichman 
(2011) 
USA 7 302 11 559 1.5(0.43-5.14) 0.53 
Manning 
(2007) 
USA 42 682 2752 14889 0.32(0.24-0.44) <0.001 
Mayer (2012) USA 1 33 5 360 2.5(0.27-22.8) 0.42 
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Figure 4.5: Forest plot of injection drug use compared to non- injection drug use for 
acquiring sexually transmitted infections among people living with HIV in developed 
countries 
 
Heterogeneity 
Figure 4.5 above shows forest plot illustrating the heterogeneity amongst ORs for IDUs: non-
IDUS for acquiring STIs amongst PLWH in developed countries. Here the effect estimates were 
observed on both sides of the reference line and their confidence intervals poorly overlap. This 
suggest a high level of heterogeneity. The high heterogeneity across the studies was again noted 
with I² = 85% at p-value <0.001. 
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Potential publication bias 
Figure 4.6 below illustrates a funnel plot for the risk of  acquiring  STIs in a HIV- infected  IDUs 
compares to non-IDUs in developed countries. The observed  plot was asymmetrical, while 
Egger’s test p-value was 0.5.  
 
Figure 4.6: Funnel plot for the risk of acquiring sexually transmitted infections in HIV 
infected injection drug use compared to non- injection drug use in developed countries. 
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4.5 Discussion 
Globally, the prevalence of STIs has been reported to be high amongst PLWH (2) and this had 
led to increase in rate of the co-infection (4). Even though a comprehensive literature search of 
studies addressing the acquisition of other STIs amongst PLWH by gender and IDU was 
conducted, few studies were identified to fulfill our eligibility criteria. The limited articles were 
identified after screening 115 and 150 abstracts for the “gender” and “IDU” analysis respectively.  
The first systematic review and meta-analysis (gender) identified and screened 19,578 published 
articles to review gender as a risk factor for acquisition of other STIs amongst PLWH  in 
developed countries. Ten studies with 61,302 participants were eventually included in this review 
after the application of the inclusion and exclusion criteria. These studies were from 4 developed 
countries. 
 
The pooled effect estimates for the studies were calulated by using the crude estimates from each 
publication. The sample size in each publication could affect the effect estimate made available 
for the metaanalysis.  Studies with larger sample size are more likely to have higher power and 
precison compare to those  with smaller sample size. 
 
Findings for our gender query varies in the included studies. Some studies reported that HIV-
infected females had a higher tendency to acquire other STIs compared to males.(13-15, 19) 
These studies had documented various reasons that may be responsible for the acquisition of  
other STIs in women living with HIV. The study by Kalichman and colleagues in 2000 inferred 
that the OR might have been in favour of  men because women report STI symptoms more than 
men.(3)                                                                                                                                                                                                                                                                                                                  
Belongia et al. (1996) reported that women were observed to use health care services more than 
men, therefore more women were screened for STIs compared to men (13). Heilligenberg et 
al.(2012), in a study conducted in Netherland, also screened more  
HIV-infected women for STIs (58%) than men.(18) Romanoski et al. (2007), in a Canadian study 
exploring the acquisition of genital herpes in PLWH, also reported that HIV-infected females 
were more likely to be infected with other STIs than men.(19) These women were observed to 
have a higher tendency of STI acquisition because of their genital anatomy (wide vagina mucosa 
surface), which is prone to abrasions and lacerations during sexual intercourse. (19)  
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The acquisition of other STIs by HIV-infected females could also be accounted for by other 
factors, which has previously been reported to affect HIV transmission in women, one of which 
is their financial dependence on their husbands and partners. (23-26). This hinders their ability to 
have control over their body, and as such makes it difficult to negotiate safe sex (23-26), leading 
to increased risk of acquiring other STIs amongst HIV-infected women. One of the reviewed 
studies observed that more HIV-infected women than men with STI had a lower income even 
though the difference was minimal.(3) Some women with financial insecurity do engage in sex 
work in order to support themselves financially. (27) This act also limits their say in safe sex and 
increases their risk of having STIs. Another factor that could be responsible for the association 
between female gender and the likelihood of acquiring  STIs in PLWH  is sexual violence against 
women. (28) Females are reported to have a higher history of sexual violence compared to 
males.(28) Since male to female sexual transmission of HIV is more efficient than female to male 
transmission (29), these women are more likely to acquire other STIs than men.  
Other studies documented that HIV-infected males are at higher  risk of acquiring other STIs 
compare to females.(4, 12, 17) Baffi et al. (2011) reported that men living with HIV were more 
likely than women to be at risk of acquiring STIs.(12) The difference in their finding could have 
been as a result of more male participants in their study as 76% of their participants were 
male.(12) Sexual preference for majority of the men in this study was MSM, which is a group at 
high-risk of STIs.(12) Manning et al. (2007) confirmed Baffis result regarding this 
association.(4) The majority of participants in Manning’s study were men involved in MSM 
practises (4).  
Overall, the result from our meta-analysis showed no association between gender and the risk for 
acquiring other STIs amongst PLWH in developed countries. This observation was supported by  
Kalichman et al. (2011).(2) Kalichman and colleagues, in a systematic review, observed that 
HIV- infected females and males had similar risk for acquiring other STIs at 13.6% and 15.8% 
respectively(2).  
The second systematic review and meta-analysis (IDU) identified and screened 6,776 published 
articles to review IDU as a risk factor for acquisition of  other STIs amongst PLWH in developed 
countries. After the application of the inclusion and exclusion criteria, 6 studies with 56,846 
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participants were eventually included in this review. These studies were from two developed 
countries.  
Findings from the IDU query showed that some studies suggested a possible risk of acquiring 
other STIs amongst IDUs living with HIV with OR 1.5 (0.43-5.14), 2.2 (0.94-5.07) , and 2.5 
(0.27-22.8).(16, 21, 22) The observed odds by these studies might have been due to risky sexual 
behaviors amongst IDU.(16, 22) It was noted that PLWH continue having risky sexual behaviors 
after being diagnosed with HIV.(30, 31) Bachman et al. (2005), in a cross sectional study based 
on  illicit drug use and not IDU alone, discovered that illicit drug users living with HIV  are more 
likely to have STI compare to non users.(32) They observed that despite being infected with HIV, 
their participants still engage in unprotected sexual activities via various route (oral,vagina, 
receptive and insertive anal).(32) Bachman et al. also recorded a four times likelihood of 
engaging in high-risk sexual behavior when under the influence of illicit drugs.(32) Similarly, 
Stueve et al., observed a relationship between high-risk sexual behavior and being “high” after 
the use of an illicit drug with OR of 1.66.(33) 
 In another study based on illicit drug use by Kalichman et al.(2000), HIV-infected persons on 
illicit drugs were almost two times more likely to acquire other STIs.(3) Kalichman and his 
colleagues also observed  an increase in the rate of unprotected anal and vaginal sexual 
intercourse amongst these groups.(3) The results in these studies  might have favoured non-drug 
users because the majority of their participants were males.(3, 32) This disproportional 
representation of males in these studies might be responsible for the results, particularly because 
men have a higher tendency of engaging in substance abuse.(34) Another factor that may be 
responsible for the illicit drug use association is the recruitment site. Study population for 
Kalichman research was from an infectious disease clinic (3), so it is likely that their sample was 
made up of HIV-infected substance users  with STIs or symptoms of STIs infection. 
Other studies did not report any association between  acquiring other STIs amongst IDUs living 
with HIV (4, 15, 17), but none of these studies documented reasons  for this finding. 
Even though in other literature the prevalence of STIs tends to rise in the face of drug use (35, 
36), this meta-analysis did not observe an association between IDU and the acquisition of other 
STIs amongst PLWH in developed countries.  
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The study heterogeneity for the gender and IDU analysis were both high at 96% and 85%, 
respectively. The high heterogeneity may have been due to dissimilarities in the studies with 
respect to participants, outcome, study design, risk of bias, and effect estimates. (20) The 
presence of enormous amount of heterogeneity amongst the studies reviewed for the two 
questions showed that the result of this study can not be generalized. Our findings points out that 
it is essential to know and understand one’s local epidemic.(37) 
The asymmetrical funnel plot observed in both analyses suggest the presence of publication bias. 
However, Egger’s test p-value for the two analysis refute this observation. Thus, the 
asymmetrical funnel plot observed in our analysis could be due to other factors such as reporting 
bias, particularly since our study eliminated non- English studies. (20, 38) Another factor 
implicated for the asymmetrical funnel plot is the weak methodological rating of most of our 
studies, which leads to false overestimated effect estimates. (20, 38) 
Even though there was no association between either gender or IDU  and the risk of  acquiring 
STIs among PLWH in developed countries, this does not imply that the two risk factors should 
be ignored in the fight against acquisition of STIs among PWLH. Rather, program development 
should take into consideration the essential needs of both males and females living with HIV. 
Also, special programs might be required to reach certain high-risk groups such as sex workers 
and IDUs. Some studies documented that  IDUs  living with HIV are less likely to use health 
services when compared to other PLWH.(39, 40)The use of intravenous drugs increases unsafe 
sexual behavior (14), and thus the possibility of transmitting or acquiring STIs in PLWH. While 
under the influence of drugs,   decision-making is impaired and this gives the feeling of a rise in 
sexual pleasure that increases sexual activity.(14) This results in several risky sexual behaviors 
such as unprotected sex or having sex with multiple, casual, HIV-infected, or IDU partners.(32) 
Sexually transmitted infections can also be acquired in PLWH by exchanging sex for drugs or 
money to buy drugs.(14) 
Reviewed studies emphasized that high-risk behaviors contribute a great deal to the likelihood of 
acquiring STIs in PLWH. Individuals living with HIV continously engage in high risk sexual 
behavior, which increases their risk of acquiring other STIs and also transmission of HIV.(3, 4, 
12, 32) Thus, high-risk sexual behavior and substance abuse should be given attention when 
considering intervention programs for this population (32).  
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Incorporating safe drug use program into sexual health programs is highly beneficial.(12) 
Relevant drug screening tools should be developed for use at the sexual health clinic.(12) 
Individuals established as having drug problems should then be referred to appropriate treatment 
facilities, such as supervised injection facilities (SIF). Supervised injection facilities could help 
decrease risky behavior, STIs, drug overdose, and death associated with illicit drug users.(41) 
During service delivery at these centers, emphasis should be placed on the risk of acquiring other 
STIs and also on further transmission of HIV. These programs will help to modify both sexual 
and drug use behaviors of  at risk individuals with the final outcome of decreasing the prevalence 
of STI in PLWH.(3, 32) 
Screening and treatment for STIs amongst PLWH, is another important  useful intervention 
program.(3,15, 21, 32) Several studies have reported the difficulty in ascribing a temporal 
causation to the relationship between HIV and other STIs.(42) Even though, these STIs might 
have been discovered after HIV diagnosis, they might have been present in these individuals prior 
to HIV diagnosis (15, 43). Sexually transmitted infections remain undiagnosed without screening 
programs. Although, some nations have screening guidelines, health providers do not implement 
these guidelines.(12) Thus, STIs prevention policy in various countries should include educating 
the health providers to implement STIs guidelines aggressively. This move will help to reduce 
the incidence of STIs among PLWH.(12)  
Strength and Limitations  
To the best of our knowledge, this is the first systematic review and meta-analyses examining if 
gender or IDU is a risk factor for acquiring other STIs amongst PLWH in developed 
countries.The presence of other STIs among PLWH is regarded as an indicator of high-risk 
sexual behaviors.(44) Exploring these factors helps to identify factors contributing to acquisition 
of other STIs in PLWH in developed countries, and subsequently guide the choice of intervention 
programs that can help to prevent other STIs.  
With meta-analysis been the highest level of evidence in research, and the fact that a 
comprehensive, rigorous literature search, and screening according to MOSSE guideline was 
conducted, the findings from this study could help developed countries identify factors 
implicated in acquiring STIs in PLWH . 
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This systematic review and meta-analysis has some limitations that are worth noting. Limited 
number of articles were reviewed for the two research questions. This is an undeniable limitation. 
However, it is imperative that inclusion and exclusion criteria needs to be applied stringently. 
Relevant data and information might have been missed by not using grey literature, although the 
grey literatures might have incomplete data. 
Our systematic review and meta-analysis was limited by the quality of the original reviewed 
studies. However, since the data were gathered systematically from eligible studies it strengthens 
the associations of the risk factors (gender or IDU) and acquisition of other STIs in PLWH .  
The weak methodological rating of most of the included articles is not a surprising finding in 
observational studies because all the mentioned components assessed in the EPHPP assessment 
tool are usually not well addressed in observational studies. However, the large number of 
participants in both reviews gave a high power and thus increases the impact of the study.  
After applying the inclusion and exclusion criteria, the study ended up  reviewing studies from 4 
developed countries for the gender review, and only 2 developed countries for the IDU review, 
with the majority of the studies being from USA. This may affects its generalizability to other 
developed countries and even developing countries. However, because the sample size  is large 
for both review  we can attempt to adapt these findings.  
Lastly, the high level of heterogeneity among the studies implies significant dissimilarities in the 
studies and their strength of association, however, the analysis still gave us insight into what the 
association  between the risk factors (gender or IDU) and acquisition of other STIs in PLWH  
looks like. The heterogeneity in these analysis can be subsequently reduce by sub-group analysis. 
In- spite, of these limitations, the findings from the review is very essential for public and 
preventive health practitioners. 
4.6 Conclusion 
The presence of a large  amount of heterogeneity amongst the studies reviewed for the two 
questions signals the importance of knowledge and understanding of local epidemics, such that 
intervention programs could be directed to the identified factors. In resource limited setting, 
programs should be prioritise for the HIV-infected subgroup, since they continue in their high-
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risk behaviors after been diagnosed with HIV. These programs help to reduce the likelihood of 
acquiring other STIs, and subsequently decreases further HIV transmission. 
In this meta-analysis, we explored the independent association of gender or IDU and acquisition 
of other STIs in PLWH in developed countries. The review observed no association between each 
of the risk factors and the risk of acquiring STIs in PLWH in developed countries. Due to the 
time frame of this study, we were not able to include non-English and grey studies in our 
analysis. Thus, another study exploring the same reseach question, but this time including non-
English and grey studies in their review will be very useful. This will enrich study results by 
limiting publication and reporting bias. It will also increase the study power, and may help with 
generalization of study results. The propose study should also consider sub-group analysis in-
order to reduce heterogeneity observed in our analysis. 
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Chapter 5: General discussion and conclusion 
This chapter will give a general discussion and conclusion on the study. The study explored the 
association between gender and the risk for STI acquisition in HIV in two manuscripts. It also 
explored IDU as a risk factor for STI acquisition in HIV. The first manuscript assessed the 
association between these variables using SHR health services data on PLWH, considering STIs 
acquired within a year before and after HIV diagnosis. The second manuscript explored these 
associations in developed countries through a systematic literature review and meta-analysis of 
studies. It considered STIs acquired after HIV diagnosis. 
5.1. Manuscript 1 
The purpose of the first manuscript was to assess if either gender or IDU are risk factors for STI 
acquisition in the year before and after HIV diagnosis in SHR.This study was conducted due to 
the paucity of literature on acquisition of STIs among PLWH in SHR, and also in Canada. 
Saskatoon Health Region health services data on PLWH during the years 2009 to 2014 was used 
for the analysis. The study population was limited to reported HIV-infected patients with and 
without STI acquisition (within a year before and after HIV diagnosis).  Our study compared two 
groups; the first had STI acquisition, while the second  did not. Out of 339 newly reported HIV 
clients in SHR, 22 and 133 clients met the inclusion criteria for  the first and second group 
respectively. The study was guided with the use of the proximate-determinants framework on 
distribution and determinants of HIV and other STIs (1), independent variables explored includes 
demographical and behavioral factors.  
Our literature search did not reveal studies exploring  risk factors for STI acquisition both before 
and after HIV diagnosis. Research which examined risk factors that may affect STI acquisition 
before HIV diagnosis were also very limited . Therefore, studies included in this paper explored 
the risk of STI acquisition after HIV diagnosis. 
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One of  the findings from the first manuscript was that being a female significantly contributes to 
the risk for STI acquisition in the year before or after HIV diagnosis in SHR. Several studies 
exploring acquisition of STI post HIV diagnosis had similar findings .(2-5) While  the  results 
from some other studies contradicted ours.(6-8) There was no association between the use of  
intravenous drug and the risk  for STI acquisition in the year before or after HIV diagnosis in the 
health region. This finding was backed by results from other studies which examined STI 
acquisition post HIV diagnosis.(4, 6, 8) 
Sex work by PLWH in SHR was also found to be associated with the risk  for STI acquisition in 
the year before and after HIV diagnosis. This observation was supported by a number of studies 
on STI acquisition post HIV diagnosis.(9-12)  
Our study is the first of its kind in SHR and Saskatchewan that assessed factors contributing to 
the risk for STI acquisition in HIV. It also contributes immensely to the body of knowledge on 
this topic in Canada at large. The identification of risk factors (female, sex work) that may 
increase the risk for STI acquisition in HIV, could help guide public health practitioners and 
policy makers on what preventive program to focus on. Consequently, preventing or reducing 
acquisition and trasmission of other STIs in PLWH, and also preventing further HIV trasmission.  
Even though, the study is the first of its kind to identify risk factors that could be responsible for 
STI acquisition among PLWH in SHR, its findings are prone to  bias that could arise from 
selection of participants into the 2 groups compared for this study 
5.2. Manuscript 2 
Systematic literature review and meta-analysis of studies exploring risk factors for acquiring STIs 
among PLWH in developed countries was conducted because of the limitation of SHR health 
services data. The systematic literature review and meta-analysis was amalgamated findings from 
published articles which explored factors that contribute to acquisition of other STIs in PLWH.  
Its first objective determined if gender is a risk factor for acquiring STIs among PLWH  in 
developed countries. The second objective assessed if IDU is a risk factor for acquiring STIs 
among PLWH in developed countries. The review was conducted with groups of search terms: 
human immunodeficiency virus, risk factors (gender OR intravenous drug use), sexually 
transmitted infections, and develop countries. Scientific databases used for the search include: 
Medline, PubMed, Embase, Proquest, Public health, and Global health. Data screening, 
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extraction and quality assessment was then carried out by three reviewers. The review identified 
ten articles for the assessment of the association between gender and risk for acquiring STIs 
among PLWH in developed countries.  In addition, it identified six studies to assess the 
association between IDU and risk for acquiring STIs among PLWH in developed countries. 
The “gender” based systematic review, identified 6 of 10 reviewed articles to be of ‘weak’ 
quality (2, 3, 5, 13-15), 3 of moderate rating(6, 8, 16), and the last of strong methodological 
quality(4). Three study designs were identified by the review, this includes cross sectional 
studies(3, 5, 14), prospective (6, 13, 15), and retrospective cohort studies (2, 4, 8, 16). Four of the 
studies had the odds of  HIV-infected female acquiring other STIs compared to that of males to 
be greater than 1 at p-value <0.05 .(2-5) The forest plot ( Figure 4.3 ), illustrated a pooled OR for 
HIV-infected females acquiring other STIs compared to males as 1.38, CI (0.75-2.55), showing 
no association between gender and the risk for acquiring other STIs amongst PLWH in developed 
countries 
The “IDU” based systematic review identified six studies to satisfy the inclusion criteria for the 
second query “To determine if IDU is a risk factor for acquiring STIs among PLWH in 
developed countries”. Half of these studies were found to have moderate methodological quality 
(6, 8, 17), 2 strong (4, 11), and the last had a weak rating(14). This review also identified three 
study designs, namely retrospective cohort (4, 8, 11), prospective cohort (6, 17), and cross 
sectional studies.(14) The OR for IDUs compared to non-IDUs for acquiring STIs among PLWH  
in this review ranged from 0.33 to 2.48(4, 6, 8, 11, 14, 17), at p-value <0.05.The forest plot 
(Figure 4.5), showed a pooled OR for IDUs for acquiring STIs among PLWH compared to non-
IDUs as 0.71, CI (0.40-1.29) indicating no association between IDU and the likelihood of having 
STIs among PLWH in developed countries.  
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     Given the high heterogeneity observed amongst the studies, the review was not be able to make a 
definitive conclusion on the independent association between gender or IDU and the risk of 
acquiring other STIs in PLWH in developed countries . The high heterogeneities could have 
resulted from variation in study design, population character, sample size, local condition and 
statistical analysis. In addition, a number of the studies used for the reviews were cross sectional 
studies, which have the limitation of ascertaining temporality of causation, even though some of 
the reviewed studies were cohort studies (retrospective and prospective). 
5.3. Study Implications  
Human immunodeficiency virus disease progression has been and it is still a concern in this 
population, and an important factor to be considered in disease progression is the acquisition of 
other STIs. In that case, attention should be paid to factors identified by this study to be 
contributing to the acquisition of other STIs in PLWH in SHR, and the world at large. These may 
help reduce HIV transmission and progression.  
The findings from this study will also inform public health practitioners and policy makers, such 
that they can make evidence based decisions. Public health practitioners and policy makers in 
resource limited setting could prioritize preventive programs, targeting reduction of STIs in 
PLWH based on our findings. The high heterogeneity in our review also implies that it is 
essential to be aware of ones local epidemic. A good understanding of local epidemics with 
respect to STI acquisition in HIV could help with effective program planning. 
The result from the first manuscipt showed that HIV-infected female were more at risk for STI 
acquisition in the year before and after HIV diagnosis. While that for the second manuscript 
showed no  consistent and significant association between gender and the risk for acquiring STIs 
among PLWH in developed countries. 
Eventhough, findings from the two manuscripts did not show an association between IDU and 
the risk for STI acquisition in HIV, existing literature do describe a relation between IDU  and 
unsafe sexual behavior (15,18Kalich 2000, bachman 2005?),, and subsequently the possibility of 
transmitting or acquiring STIs in PLWH. The use of drugs  impairs the ability to make good 
decisions, which may lead to unsafe sexual practises.(3) Sexually transmitted infections can also 
be acquired in PLWH through exchange of sex for drugs or money to buy drugs.(3) 
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The above results do not imply that prevention and curative services should be restricted to 
females alone. Rather, both genders and their needs should be considered in program 
development because neglecting males could lead to a subsequent increase in the prevalence of 
STIs amongst PLWH. Special programs might also be necessary to reach certain high-risk 
groups.  
It is important to note that behaviour does not necessarily change after HIV diagnosis, individuals 
with risk behaviour before HIV diagnosis often continue to engage in the same risks after being  
diagnosed with HIV infection.(11) Thus, intervention programs to address findings from both 
first and second manuscript may be similar. 
The presence of STIs amongst PLWH is a major health issue. (19) These STIs further depress the 
immunity of an HIV-infected person (16), and also increase their VL. (20-22) This exposes them 
to frequent STIs acquisition, HIV transmission, and transmission of resistance strains for those on 
ART.(3, 15, 18, 23) Considering the effect of other STIs on PLWH both before and after HIV 
diagnosis, it is highly recommended to carry out regular STIs screening in high-risk 
individuals.(4, 11, 15, 16, 18) Particularly because STIs might be asymptomatic, especially in 
women.(4, 5, 24) Identifying and treating STIs promptly reduces the above mentioned risk.(5) In 
order to attain a reduction in the incidence of STIs both before and after HIV diagnosis, health 
care providers should also be dedicated to the use of STIs screening guidelines in various 
clinics.(16), particularly when in contact with a high risk client. 
Another important aspect of intervention programs is to give consideration to is health 
promotion, health education, and behavioral counselling promoting messages on safe sex and 
drug use.(8, 25) It is important to note that all of the reviewed papers identified risky behavior 
amongst PLWH as a major factor facilitating acquisition of STI in PLWH. An important 
component of the health education messages should be consistent condom use.(4, 15, 18) 
Emphasis should also be placed on the risk for STI acquisition and further transmission of HIV 
during these sessions. In a US study among teenagers visiting STI clinic, 90% of males and 
96.2% of females recorded inconsistent condom use with regular partners, and 64% of all 
participants with casual partners. (26) This finding was seconded by Minoz et al., in their study 
in Spain, in which inconsistent condom use was recorded in 93.9% of their participants. (27) It is 
important to continuously remind PLWH about safe sex and drug practices to stop acquisition of 
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STIs among this group, and also prevent further HIV transmission.(3, 8, 25) It has been observed 
that emphasis during HIV counselling on avoiding risky behavior leads to behavioral changes. 
(28-32) 
Even though, the two manuscripts did not explore the use of ART in PLWH, commencing ART 
in this population has been recommended to reduce the risk for STI acquisition in HIV.(3, 4) 
Availability of ART suppresses the viral load, and boost CD4 of these individuals, increasing 
their immunity (3, 4), thus reducing the risk of acquisition of other STIs in PLWH and further 
HIV transmission.(3, 4) The improvement in the CD4 and VL seen in this group might have been 
due to their continuous exposure to health education and behavioral counselling on safe sex and 
drug use practices, which usually occurs during their follow up sessions.(3, 4)   
Depending on one’s local epidemics, instituting appropriate reduction program might reduce 
acquisition of STIs in PLWH. Despite most countries involvement in NEP, HIV incidence from 
IDU still remain high (33), one of the reasons for the increase might be from habitual needle 
sharing.(34) This indicates that just making new needles available for this group is not enough to 
prevent high-risk behaviors. Countries could also consider supervised injection facilities (SIF) 
programs, in their fight to reduce high-risk behaviors.(35-37) A study conducted by Tyndall and 
colleagues (2006), recorded that out of over 4700 IDUs using the SIF, 2171 referrals were 
made.(37) These referrals were made to addiction counsellors, detoxification centers, community 
clinics, housing, and methadone centers.(37) This could eventually lead to the reduction in drug 
use, and subsequently a decrease in high risk sexual behavior. 
The will power of policy makers is highly essential to the success of any preventive/public health 
program. The proposed SIFs in Montreal and Quebec were not only approved by the Supreme 
court, the program was also supported by the city.(35) The city came up with a multi - site 
approach, knowing that IDUs are distributed across the city.(35) However, the Montreal mayor 
refused SIF opening in one of the neighborhoods with large number of IDU.(35) In order to 
successfully prevent the acquisition of STIs in PLWH and also further HIV transmission, the will 
power of policy makers is greatly required. This is not just for SIF programs but for all programs, 
because they are the ones to make the resources (material and financial) available. 
 
 
130 
  
5.4. Conclusion and future research directions 
After investigating SHR health services data on PLWH, the study found that being a female 
significantly contributes to the risk for STI acquisition in the year before and after HIV diagnosis, 
in SHR. On the contrary, use of intravenous drug was not found to be associated with STI 
acquisition in the year before and after HIV diagnosis in the region. 
The systematic review and meta-analysis showed no association between gender or IDU and the 
risk of  acquiring other STIs in PLWH in developed countries. High heterogeneity was detected 
amongst the studies, and this could have been due to variation in the studies included for the 
reviews. Considering the heterogeneity amongst the studies, the review might not be able to make 
a definitive conclusion on the independent association between gender or IDU and the risk of 
acquiring other STIs in PLWH in developed countries . The high heterogeneity in the second 
manuscript and the findings from the first suggest that it is essential to know one’s local 
epidemics. This is key to prioritization of preventive programs. 
Although findings from both manuscripts will contribute to bridging the knowledge gaps, with 
regards to independent relationship between gender or IDU and STI acquisition in HIV, more 
research is still needed to better understand these associations. Future  research exploring these 
associations, and also considering STI acquisition  after HIV diagnosis  is highly necessary in 
both SHR and the world at large. This research should consider a larger sample size, and a longer 
follow up time.  A larger sample size will increase the study power, while a  longer follow up 
period will give time to identify factors that could contribute to the risk for STI acquisition in 
HIV. This will improve the quality of data available for analysis in this population. Another study 
with a larger participants, examining HIV-infected women only, and assessing factors that may 
influence their acquisition of other STIs will also be helpful. 
The two suggested research will help to better understand these associations. These will better 
assist public health practitioners to make informed decision in terms of policy development and 
programs addressing acquisition of STIs in HIV. 
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Appendix A: HIV case reporting form 
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Appendix B: Ethnicity description 
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Appendix C. Exposure category (Risk actor) hierarchy 
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In Canada, primary risk is assigned to an individual with multiple risks. This shows the most 
likely route of transmission. Primary risk uses a hierarchy of risk to assign probable exposure 
category, with the aid of the following ranking (highest to lowest): 
Perinatal transmission 
IDU 
MSM & IDU 
MSM 
Endemic Country 
Heterosexual Sex 
Please note that assigning primary transmission risk does not necessarily mean transmission 
occurred by that exposure category.  For instance, an individual who is engaged in sex work, who 
also practices injection drug and heterosexual, would be assigned the primary transmission risk 
IDU since it is the highest in the hierarchy. Yet, it is possible that HIV transmission occurred via 
heterosexual sex.  As a result of this, it is better to include all risk factors in predictive a 
modeling.  
 
 
 
139 
  
Appendix D: MEDLINE search strategy 
1. exp sexually transmitted diseases/  
2. HIV.mp. or exp human immunodeficiency viruses/  
3. (HIV infections or Human immunodeficiency viruses).sh. or human immunodeficiency 
syndrome.mp. or HIV-1 infections.sh. or acquired immune deficiency syndrome.sh. or Human 
immunodeficiency virus 1.od. 
4. human immun*.mp.  
5. HIV infection.mp. or exp HIV infections/  
6. (Human immunodeficiency viruses or HIV infections).sh. or HIV infect*.mp.  
7. HIV prevalence.mp. or human immunodeficiency viruses.sh. or HIV infections.sh. or 
seroprevalence.sh.  
8. AIDS.mp. or exp acquired immune deficiency syndrome/ 
9. acquire immunodeficiency syndrome.mp. or human immunodeficiency viruses.sh. or acquired 
immune deficiency syndrome.sh. or HIV infections.sh.  
10. 2or 3 or 4 or 5 or 6 or 7 or 8 or 9  
11. injecting drug abuse.mp. or exp injecting drug abuse/  
12. (drug abuse or injecting drug abuse).sh. or intravenous drug abuse.mp. or injecting drug 
users.sh.  
13. injecting drug user.mp. or exp injecting drug users/  
14. injecting drug users.sh. or IDU.mp. or injecting drug abuse.sh. or needle sharing.sh.  
15. injecting drug users.sh. or substance abuse injection.mp. or injecting drug abuse.sh.  
16. inject* drug abuse.mp. or injecting drug abuse.sh. or injecting drug users.sh. or drug 
addiction.sh. or needle exchange schemes.sh.  
17. substance abuse inject*.mp. or substance abuse.sh.  
18. heroin.sh. or heroine.mp.  
19. drug addiction.sh. or heroine dependence.mp. or drug abuse.sh.  
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20. drug addiction.mp. or exp drug addiction/  
21. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20  
22. exp females/ or female.mp.  
23. male.mp. or exp males/  
24. developed country.mp. or exp Developed Countries/  
25. developed nation.mp.  
26. 24 or 25  
27. portugal.mp. or exp Portugal/  
28. spain.mp. or exp Spain/  
29. united kingdom.mp. or exp UK/  
30. exp South Australia/ or australia.mp. or exp Australia/ or exp Western Australia/  
31. exp France/ or exp Central France/ or france.mp.  
32. austria.mp. or exp Austria/  
33. "Irish Republic AND/OR Northern Ireland"/  
34. italy.mp. or exp Italy/  
35. exp Netherlands/ or netherland.mp.  
36 sweden.mp. or exp Sweden/  
37. USA.gl. or united states.mp.  
38. canada.mp. or exp Canada/  
39. estonia.mp. or exp Estonia/  
40. latvia.mp. or exp Latvia/  
41. belgium.mp. or exp Belgium/  
42. denmark.mp. or exp Denmark/  
43. exp Finland/ or finland.mp.  
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44. germany.mp. or exp Germany/  
45. greece.mp. or exp Greece/  
46. luxembourg.mp. or exp Luxembourg/  
47. bulgaria.mp. or exp Bulgaria/  
48. croatia.mp. or exp Croatia/  
49. exp Japan/ or japan.mp.  
50. new zealand.mp. or exp New Zealand/  
51. exp Iceland/ or iceland.mp.  
52. norway.mp. or exp Norway/  
53. switzerland.mp. or exp Switzerland/  
54. slovenia.mp. or exp Slovenia/  
55. slovakia.mp. or exp Slovakia/  
56. romania.mp. or exp Romania/  
57. poland.mp. or exp Poland/  
58. malta.mp. or exp Malta/  
59. lithuania.mp. or exp Lithuania/  
60. hungary.mp. or exp Hungary/  
61. czech republic.mp. or exp Czech Republic/  
62. cyprus.mp. or exp Cyprus/  
63. sexually transmitted diseases.mp. or exp sexually transmitted diseases/  
64. Sexually Transmitted infections.mp. or exp sexually transmitted diseases/  
65. STI.mp. or syphilis.sh. or Treponema pallidum.od. or Chlamydia trachomatis.od. or disease 
prevalence.sh. or sexually transmitted diseases.sh.  
66. std.mp. or Chlamydia trachomatis.od. or sexually transmitted diseases.sh.  
67. exp syphilis/ or Syphilis.mp.  
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68. Treponema pallidum.od. or bacterial diseases.sh. or syphilis.sh. or Chancre.mp. or sexually 
transmitted diseases.sh.  
69. Treponema pallidum.mp. or exp Treponema pallidum/  
70. chancroid.mp. or exp chancroid/  
71. Haemophilus ducreyi.mp. or exp Haemophilus ducreyi/  
72. disease prevalence.sh. or Neisseria gonorrhoeae.od. or Gonorrhea.mp. or syphilis.sh. or 
Treponema pallidum.od. or sexually transmitted diseases.sh. or gonorrhoea.sh. or Chlamydia 
trachomatis.od. or bacterial diseases.sh.  
73. Neisseria Gonorrhoeae.mp. or exp Neisseria gonorrhoeae/  
74. sexually transmitted diseases.sh. or Chlamydia.od. or Chlamydia infections.mp. or bacterial 
diseases.sh. or Chlamydia trachomatis.od. or disease prevalence.sh. 
75. Chlamydia trachomatis.mp. or exp Chlamydia trachomatis/  
76. (sexually transmitted diseases or herpes simplex viruses).sh. or Herpes genitalis.mp. or herpes 
simplex.sh. or Human herpesvirus 2.od. or herpes simplex genitalis.sh.  
77. Herpes Simplex.mp. or exp herpes simplex/  
78. Herpesvirus 2.mp.  
79. Lymphogranuloma venereum.mp. or sexually transmitted diseases.sh. or bacterial diseases.sh. 
or disease prevalence.sh. or Chlamydia trachomatis.od.  
80. Trichomonas vaginitis.mp. or trichomoniasis.sh. or bacterial diseases.sh. or sexually 
transmitted diseases.sh. or Trichomonas vaginalis.od.  
81. 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 
79 or 80  
82. 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 
43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 
or 60 or 61or 62  
83. 26 or 82  
84. 1 or 81  
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85. 22 and 23 
86. 10 and 83 and 84 and 85 
87. 10 and 21 and 83 and 84   
88. limit 87 to (humans and yr="1985 - 2016")  
89. limit 88 to english language  
90. limit 86 to humans  
91. limit 90 to yr="1985 -Current"  
92. limit 91 to english language  
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Appendix E : Quality assessement tool for quantitative studies 
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Appendix F: Quality assesemment tool for qualitative studies dictionary 
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